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Glossary and notes on terminology 
 
• EoL – End of Life. 
• PC – Palliative Care. 
• REA – Rapid Evidence Assessment. 
• KI – Key informant. 
• OST – Opioid Substitution Therapy. 
• Client/patient – these terms have been used interchangeably to reflect the terms used 
by interviewees. They refer to the person receiving the service they offer.   
• PWE – Person with Experience. This is the preferred term of the research team for a 
person with both substance use and end of life care needs who may, or may not, be 
using a service. 
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Executive Summary 
1. The aim of the Key Informant (KI) interviews was to investigate existing models of 
practice or care pathways for supporting adults with substance problems needing end of 
life care, and their families/carers, from the perspective of people who were living or 
working with these overlapping issues or in close proximity to them.  The interviews 
were conducted at the start of the project so their findings could inform our 
understanding of some of the key policy and practice challenges faced by those working, 
and living with, people with substance problems and end of life or palliative care 
conditions.  They also helped to shape our thinking about the wider project design. 
2. A total of 17 interviews were completed with 20 people – 16 professionals, one service 
user and three family members from the same family.  The professionals were a diverse 
group with expertise in palliative and EoL care, and substance use.   
3. Template analysis of the interview data identified two overarching themes:  i) the wider 
landscape of EoL care and substance use service provision; and ii) engaging and 
responding to people at the end of their lives who have a history of problematic 
substance use.   
4. These two overarching themes included seven broad themes:  i) the size and nature of 
the problem; ii) service commissioning and delivery; iii) definitions and perceptions of 
substance use and end of life; iv) engaging clients; v) (not) talking about the issues; vi) 
managing and developing care responses; and vii) families and networks.  
5. There are six headline findings from the analysis: 
i. First, current definitions and ways of understanding palliative care, and substance 
use recovery, do not easily apply to people with current or previous problematic 
substance use and EoL conditions.   
i. Second, this group of people is not a straightforward one – there are often 
complex and multiple physical, psychological and social morbidities which impact 
upon their identification, engagement with services and the delivery of care.   
ii. Third, there are significant issues with the fragmentation and inflexibility of service 
providers which affect the care they receive.  However, it is possible to identify the 
characteristics of a good joined-up and compassionate approach to care.   
iii. Fourth, substance use receives little attention in national or local policy around 
palliative and EoL care; and palliative and EoL care receives little attention in 
national or local policy around substance use.   
iv. Fifth, prescribing for pain and/or symptom management for people with substance 
use and EoL conditions is a complex area but good practice is achievable.   
v. Finally, family members of people with substance problems at the end of their lives 
can be viewed negatively, and receive little support both at the end of their 
relative’s life and after their death.   
6. The KI interviews have given a unique, and hitherto unknown, insight in to the 
experiences and challenges of working with adults with substance use problems and life 
limiting conditions. Interviewees identified numerous individual, organisational, and 
strategic challenges to identifying this group and delivering timely, efficient, joined up 
and compassionate care. It is clear that there is much to do to better meet the needs of 
a sizeable, but largely neglected group of adults and their families – these interviews 
offer constructive suggestions for how care can be improved.  
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Section 1 - Background 
There are growing public health concerns about the morbidity and mortality of people with 
alcohol and/or drug problems and the care which they receive, the current climate in which 
substance use treatment services are commissioned and delivered, and inequalities in 
substance use treatment, palliative care (PC) and end of life (EoL) care (ACMD, 2017; Adfam, 
2017; Aldridge et al., 2017; CQC, 2016; Marie Curie, 2015).   
 
The experiences and needs of families of people with substance use problems, including 
those who have been bereaved by substance use, have also been highlighted (Andersson et 
al., 2018; Valentine, 2018).  Overall, however, there is a paucity of research about EoL care 
for people with substance use problems and their families, and a lack of policy and practice 
attention about the specific experiences and needs of these cohorts of patients and families 
and of the professionals who have contact with them.  There has also been a lack of 
research which has investigated professional views on caring for this group of patients and 
their families.  
 
Our programme of research on End of Life Care for People with Alcohol and Other Drug 
Problems has six strands. This report presents data from Strand 6, which aimed to 
investigate existing models of practice and care for supporting people with substance 
problems needing end of life care and their families/carers.  The remaining sections of this 
report outline the methodology employed to conduct and analyse the interviews, the 
findings, and a discussion of the key issues.   
 
Ethical approval for the KI interview study was obtained from Manchester Metropolitan 
University (ethics application 1389). Given the mixed methods nature of the wider 
programme of research, ethical approval was sought solely for qualitative data collection 
from key informants for this strand and from strand 5 of the research focussing on 
professionals working within our partner agencies. Informed consent was given by all 
participants. 
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Section 2 - Methodology 
2.1  Overview 
At the start of this project, the research team identified a number of individuals, Key 
Informants (KI), who worked in this, or a related, area through contacts in both substance 
use and EoL services and through existing literature on the topic.  To ensure the project was 
asking the right questions, and doing so from a point of some knowledge, we decided to 
conduct a small number of interviews with these key individuals.  This would ensure that, 
for example, the Rapid Evidence Assessment (REA) was using the correct search terms and 
exploring all relevant literature.  As we spoke to people they told us of others and the group 
of individuals grew.  It was clear that the data emerging from these discussions was hugely 
informative, particularly given the range of people we spoke to and their varying 
professional and personal experiences.  It therefore became a full additional strand of 
research and developed into a small semi-structured interview study, rather than simply a 
consultation to inform the questions and parameters of the REA.  The KI interviews also 
informed the development of Strand 5 of the project which sought to identify what 
challenges and opportunities professionals face when supporting people with substance 
problems and chronic or terminal illness. 
 
2.2  Recruitment of interviewees 
Recruitment was an iterative process which combined purposive and snowball sampling.  
The aim was to select individuals working both nationally1 and locally from a range of 
disciplines and perspectives (policy, practice, research) and from both the substance use 
and EoL fields.  Some interviewees were found through existing literature, others were 
already known to members of the research team, while the remainder were suggested by KI 
themselves.  The original aim was for approximately 15 interviews – this target was set 
pragmatically rather than with an aim of data saturation or comprehensiveness, and was 
deemed appropriate for the exploratory nature of the project.   
 
2.3  Interview process 
The interviews were undertaken by one researcher2.  Semi-structured interviews meant that 
there could be a focus on a priori topics identified by the researcher while allowing for 
flexibility to explore and develop the participants’ responses.  The interview guide was 
developed in collaboration with members of the research team based on the project’s main 
research questions.  As the KI interviews were at the early stages of the research, the topic 
guide identified broad questions relating to the person’s experience of working, or living 
with, both substance use and end of life care.  These included: 
 
i. Asking about the key challenges and opportunities people faced when someone had 
both substance use and end of life care needs.  
ii. Identifying, where possible, current models of practice at individual and 
organisational levels.  
iii. The relevance of the policy context at regional and national levels.  
                                                     
1 Usually in England or Wales although one interviewee was based in Scotland.  
2 The PI (Principal Investigator) completed one interview.    
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iv. The organisations people work with or access.  
v. Any awareness of projects already working in this area.  
 
The early interviews led to some minor changes being made, for example the order in which 
topics were explored in the interviews.  Interviewees tended to speak freely about their 
experiences and views meaning there was a need to refine the questions to prompt for 
more, or different, data. 
 
All the 17 interviews were conducted face-to-face; 15 in person and the remaining two 
conducted by an internet-based telecommunications system, Skype.  All interviews were 
audio-recorded and transcribed by an external transcribing agency, which had signed a non-
disclosure agreement with Manchester Metropolitan University prior to the project starting.   
 
2.4  Analysis 
Qualitative analysis was undertaken using template analysis (King, 2012), with some use of 
thematic networks to help visualise the emerging codes and themes (Attride-Stirling, 2001).  
QSR NVivo 10 was used to organise the data.  Template analysis is a form of thematic 
analysis which combines structure with flexibility and is most commonly used to analyse 
individual interviews (King, 2012).  It can combine ‘top down’ with ‘bottom up’ analysis, and 
allow the use of both a priori themes and themes which emerge from the analysis itself.  
Template analysis has been used in a qualitative study which explored family carers’ 
experiences of out-of-hours community palliative care (King, Bell & Thomas, 2016) so it was 
known to be appropriate for this area of research.  Figure 1 summarises the application of 
template analysis to the dataset of KI interviews and the final analytical template is in 
Appendix 1.   
 
A small number of broad a priori codes were considered when starting the analysis, based 
on discussions with the researcher who completed most of the interviews, the interview 
topic guide, and broad knowledge of the area and some of its literature (for example, 
through the REA).  Examples included commissioning, asking about substance use or EOL, 
and uncertain illness trajectories.  As the analysis evolved these a priori codes were 
integrated in some way as major or minor themes.  Analysis was challenging because of the 
diversity of the interviewee cohort.  This diversity meant that the early stages of analysis 
involved more reading of the transcripts so that the most representative template could be 
developed (King, 2012).  Some codes were more common across the whole dataset while 
others were relevant to subsets of interviewees (for example, according to their area of 
expertise and their focus).   
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Figure 1: Application of template analysis to KI interviews 
  
Read 9 of the 15 interviews with 
professionals, making notes of 
ideas regarding themes/codes. 
(Service user KI and family KIs not 
included at this stage) 
Prepared first draft of template, 
and a visual thematic map (to 
organise thoughts in a different 
way).
Shared template with one of the 
Co-Investigators– no changes 
made.  
Transferred template to Nvivo 
and coded all interviews.  
Checked Nvivo file - prepared 
second version of template –
removed a small number of 
nodes that had not been used, 
moved or merged some codes.  
Read the rest of the professional 
interviews.  Minor changes made 
to visual map and draft template 
(e.g. collapsing or removing 
codes, managing potential 
duplication, adding small number 
of codes).  
Read the remaining 2 transcripts 
(with service user and family) 
with a small number of very 
minor changes made to the 
template.
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Section 3 - Findings 
3.1  Description of the KI interview sample 
A total of 17 interviews were completed with 20 people.  Interviewees consisted of 16 
professionals (two were interviewed together), one person with lived experience (PWE) and 
three family members (FMs) from the same family who were interviewed together and 
talked about the same relative who had died.  The 16 professional interviewees were a 
diverse group who can be broadly grouped as follows: 
 
1. Group 1 (n=8) - Frontline health and social care professionals (HSCP) working at a 
local level – a GP (also a regional lead for substance use), a specialist EoL social 
worker, three clinical nurse specialists, a homelessness nurse specialist working in a 
hostel, a prison worker, and a specialist in EoL care and homelessness at a homeless 
charity.  
2. Group 2 (n=4) - Senior health and social care professionals working at a local level – 
a CEO of a drug/alcohol treatment service, a palliative care consultant, a consultant 
hepatologist, and a registered premises manager (bail hostel). 
3. Group 3 (n=2) - Those working nationally in policy or commissioning – one in 
substance use and one in palliative and EoL care. 
4. Group 4 (n=2) – Other Professionals – a coroner and a researcher.  
 
Analysis identified seven broad themes (see Figure 2 below) which were grouped into two 
thematic clusters.  The two clusters were ‘the wider landscape’, and ‘engaging and 
responding’.  Each of the seven themes will be discussed in turn and illustrated with 
verbatim excerpts from the interviews (quotes from the professional KI interviewees are 
classified by the groupings listed above).  
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Figure 2: Template analysis broad themes  
 
Template 
Analysis
Definitions and 
perceptions
Size and nature of 
the problem
Commissioning 
and delivery
Engaging clients
(Not) talking 
about substance 
use and death or 
dying
Managing and 
developing care 
resposnses
Families and 
networks
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3.2  Thematic Cluster 1: The Wider Landscape 
The first thematic cluster was ‘the wider landscape’, and this covered three broad themes - 
definitions; size and nature of the problem; commissioning and delivery (Figure 3).   
 
 
Figure 3: Thematic Cluster 1 - The Wider Landscape 
 
 
3.2.i  Definitions and perceptions 
Interviewees talked about how palliative and EoL care, substance misuse and recovery, and 
death and dying, are defined and how these definitions and perceptions can facilitate or 
impede care.  This theme also includes what interviewees said about how society perceives 
this group of people.  
 
Palliative and EoL care 
Interviewees talked about this at both a general level and with specific consideration of 
people with substance use problems.  At a general level some interviewees thought that 
palliative care should not be seen in “binary”, i.e. in black and white, terms and as 
something which is only about dying; rather it should be something that runs parallel to 
treatment.  In the quotes below one interviewee thought that a narrow definition of 
palliative and EoL care risked ‘giving up’ on some people, while another reflected that it 
made it harder to argue that palliative care and treatment can be delivered in parallel:   
Definitions and 
perceptions
Palliative and EoL 
care
Substance use 
and recovery
Death and dying
Perceptions of 
wider society
Size and nature of 
the problem
Prevalence and 
awareness
Client profile and 
demographics
Commissioning and 
delivery
National 
commissioning 
picture
Policy impact on 
commissioning 
and practice 
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[It feels] like it’s giving up which is very much based on this [idea of] you 
have to stop one sort of care before you start another, but I think that’s 
slowly changing and so it is improving (Group 2 - Senior HSCP) 
 
[It’s] harder to push the duality of care message (Group 3 - Policy & 
Commissioning Professionals) 
 
Other interviewees felt that the term EoL care can be too rigidly and narrowly interpreted. 
One said that using the term ‘palliative care’ (for example, when discussing palliative care 
registers) can be a “double edged sword” which can facilitate or damage interactions with 
challenging and complex patients. Such patients may feel that their situation is completely 
hopeless and continue with damaging levels of substance use as a result.  Another 
interviewee described their preferred interpretation of palliative and EoL care: 
   
…palliative care is not putting somebody into the side room in the last two 
days of life and putting on Radio 2, it’s about having a serious period of 
time where you can plan what you want to happen towards the end of 
your life... some sort of understanding of mortality can be helpful and it’s 
often done intuitively over many, many consultations and I certainly don’t 
think we should sort of be really forcing it down people’s throats, some 
people don’t want to see it but at the moment there’s just not the toolkit 
there to do it, if you want to. (Group 2 - Senior HSCP)  
 
Interviewees recognised the need to ensure that the terms palliative and EoL care are 
defined and understood in ways which ensure that they are relevant to all illnesses and 
conditions rather than their (often narrow) application to cancer:    
 
…[discussing] palliative care with people with substance use issues needs a 
bit of a re-brand...it’s a huge bombshell to drop on somebody with no plan 
of action going forward. But I do appreciate that it can, on the one hand, 
have very detrimental effects but...we need to ensure that people can 
make informed choices about their future as well...it’s a person-centred 
approach that palliative care/end of life care, needs to take… (Group 1 - 
Frontline HSCP) 
 
At least one interviewee emphasised the need to consider how to best adapt the definitions 
of palliative and EoL care for conditions like liver disease because of the unpredictability of 
the condition:  
 
So the steady decline that you see in malignancy, which is where palliative 
and end of life care developed as a specialty and a lot of the evidence base 
is around that, is not there in liver disease, so that unpredictability of the 
trajectory, which can sometimes even result in survival from the disease, 
makes it very difficult. (Group 2 - Senior HSCP) 
 
Some interviewees also identified a need to be clearer about the role of key professionals 
and services in the delivery of palliative and EoL care, such as Macmillan nurses, palliative 
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care nurse specialists and hospices.  Although not directly mentioned, the implication from 
this is that there needs to be a greater understanding that such professionals do not just 
work with cancer but are there to work with groups such as people using substances.  
 
Substance use and recovery 
When thinking about substance use and addiction, interviewees tended to focus on the 
recovery paradigm which is currently dominant in UK alcohol and drug treatment3.  There 
was consensus from many interviewees that the general definition of recovery and its 
application to treatment does not apply to those with EoL issues and that this disconnect 
makes the delivery of care extremely difficult.  As one interviewee said, “dead people don’t 
recover”.  Another interviewee talked about the focus of substance use treatment being on 
prevention, management and recovery and, as a result, ignoring the fact that some of this 
group will die:  
 
So there is something about the end of life care prospect that is invisible to 
this group of people...the talk never gets to the fact that people die, so the 
talk is always about prevention, self-care, best management and I keep 
having to say but they will die at some point so when are we going to deal 
with this?...I wonder if that is also what happens in the addiction clinics...all 
the services that have contact with this group of people, whether actually 
the focus is all on that first bit and not about, or not even acknowledging 
that last bit and I wonder why. (Group 3 - Policy & Commissioning 
Professionals) 
 
Interviewees discussed the relevance and appropriateness of recovery-oriented approaches 
within EoL care for those who cannot or do not want to ‘recover’ from their substance use. 
Some people would rather be supported to drink or take drugs at the end of their life, or 
they are not able to address the other issues which are often the focus of recovery and 
associated service targets.  A focus or insistence on recovery can alienate clients:     
 
…within the drugs movement now, there is this big push around recovery, 
recovery... for some people who find it impossible to come off drugs, 
whether just because they see that the big push is around recovery, that 
even more marginalises them because they think, ‘I can’t recover and what 
do I do?’ so all these services are badged ‘recovery’, it’s all about recovery 
and someone is coming in thinking, ‘I don't know if I can get there, I'm not 
there yet’. (Group 2 - Senior HSCP) 
 
…the majority of services really are focused on recovery – so if you've got 
somebody with liver disease that realistically isn't looking very likely to 
recover, all of the services are directed at detox and at rehab, whereas 
there’s certain people [where] that’s not going to happen or it’s unlikely to 
happen. (Group 4 – Other Professional) 
                                                     
3 In recent years stemming from a consensus statement which defined the process of recovery from substance 
use as characterised by “voluntarily-sustained control over substance use which maximises health and well-
being, and participation in the rights, roles and responsibilities of society” (UK DPC, 2008 – see 
http://www.ukdpc.org.uk/publication/recovery-consensus-group/)  
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However, one interviewee wondered if recovery was misunderstood and interpreted too 
narrowly:   
 
…what they see is a very abstinence oriented, recovery focused policy and 
we’ve been trying, we’ve been at pains since 2010 to point out that that 
isn't the policy, the policy is still one of balance, that you should have more 
ambition for people’s recovery but that that isn't the same as curtailing 
treatment or keeping people out of it. (Group 3 - Policy & Commissioning 
Professionals) 
 
Death and dying 
Interviewees talked about how death is perceived, usually in Western societies as 
something to be feared and ignored and not talked about, and how this impacts upon 
notions of what is a ‘good death’ and where the right place to die might be.  There was 
general acknowledgement from a small number of interviewees that there is discomfort in 
acknowledging that death occurs within this group of people:  
 
As soon as you come to see me, because you've got decompensated 
cirrhosis in a liver clinic, your chance of dying is high the second you walk in 
the door. We don’t really face up to that. (Group 2 - Senior HSCP) 
 
Interviewees voiced concerns that the nature of this group of people (their substance use, 
their other illnesses, and their wider personal/social circumstances) can make some 
professionals and patients question whether in fact a ‘good death’ is possible for them.  As 
will be seen later in this report, it is important that those providing care open channels of 
communication with their patients so that such feelings can be expressed and discussed:   
 
People that traditionally are taking drugs, have got a higher tolerance [of 
medication] and they’re terrified when they come to end of life of being in 
pain and not being given enough drugs... A lot of people just want 
reassurance that their end of life will be as comfortable as it can be. Again, 
it’s just getting people to voice that concern and that it will be addressed. 
(Group 1 - Frontline HSCP) 
 
Often people towards the end of life, if there are any outstanding issues, 
they become really agitated and restless and things and you can tell that 
things are mulling over in their mind and that might be something that 
they can be quite honest and say, ‘I wish that...didn’t happen’, ‘I wish I 
could have done things different” and sometimes it’s enough just to have 
had a conversation around that and acknowledge how difficult that must 
be for them. (Group 1 - Frontline HSCP)  
 
Interviewees debated what a good death and the right place of death might be for this 
group of people.  Some interviewees talked about how the circumstances of the group, and 
how their self-perceptions (or their belief in how they are perceived by others), can 
influence where they die and their views about that:   
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…all the stories that involve hospices, palliative care, end of life care, the 
‘nice’ end of that is never associated with unpopular groups; it’s never 
associated with the homeless, people in prisons, people with substance 
abuse, it’s always about people who are dearly beloved, lots of family and 
friends, children, almost as though that’s too precious for this other 
group...a beautiful hospice may feel very alien to somebody who is not 
used to that, for whom life is completely alien now anyway with facing a 
life threatening condition. (Group 3 - Policy & Commissioning 
Professionals) 
 
Further, the circumstances of some patients may mean that a hospice or home are not the 
best places for dying, and that a hospital might be the best place for EoL care and death (for 
example, when complex clinical care is required for someone with liver disease at risk of 
variceal bleeding).  However, some interviewees thought that hospital staff must be able to 
provide personal and compassionate care alongside such complex medical care:   
 
We’re a hospice and we think everybody should die in a hospice because 
that’s the place to die...or at home preferably...but actually, from what I’ve 
seen, the gentleman who’s poorly, if he dies on the ward where he goes in 
and out of all the time, that would be okay because he knows them, people 
are kind to him on there...how cocky of a hospice worker to think they 
shouldn't die in a hospital. When I was a hospital nurse, I’d have been 
really annoyed if somebody felt that I couldn't provide that care and some 
of the nurses and doctors are absolutely superb, so why not? They will die 
with dignity in a hospital but what I’d like to see and what my bosses would 
like to see is choice and that’s not what they’re getting, they get no choice. 
(Group 1 - Frontline HSCP) 
 
Other interviewees also discussed the applicability of hospice care for some sub-groups of 
people such as younger patients, homeless people or those who wish to continue drinking 
or taking drugs.  For example, the service user interviewed talked about attending a hospice 
in his mid-40s, saying that he felt he was in the “wrong place”, a view echoed by one other 
interviewee: 
 
… there’s only one other person here that’s even remotely near my age... I 
feel almost too young to be here but obviously there’s no age limit to 
illness...[I’m] definitely in a minority (Service user) 
 
…where do you place a young man who’s 35 years old, who meets the 
criteria for a care home but the care home criteria is that he has to be 65? 
And even if there wasn’t an age criteria, is that a dignified place for care for 
someone who’s young...there’s a massive gap in services for people with 
substance use issues because they’re younger, they don’t fit the bill for 
mainstream services. (Group 1 - Frontline HSCP) 
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Another important element of a good death highlighted for this group is whether or not 
they are able to, and can be supported to, continue using substances when they are dying 
(this is discussed on a few occasions throughout this report).     
 
Perceptions of wider society 
A small number of interviewees talked about how wider society can perceive this group of 
people.  They spoke of the impact that the perceived negative perceptions held by other 
people towards them can have on their accessing care.  Some interviewees expressed 
strong views that society sees this group of people as undeserving of help and that such 
perceptions are a vicious circle with patients simply reinforcing the labels that society places 
on them:   
 
…people are just like whatever, not interested. They deserve to be locked 
up and they can die in prison. That's the kind of attitude. (Group 2 - Senior 
HSCP) 
 
I think that stigmatised people often behave in a stigmatising way because 
of that, they carry the label. Therefore, their willingness to engage can be 
low...they feel that they're going to be stigmatised and therefore it's easier 
to avoid that. (Group 1 - Frontline HSCP) 
 
One interviewee suggested that wider societal views even go so far as to blame or 
scapegoat such groups of patients for the pressure which has been placed on health and 
social care systems in recent years:   
 
…whether the system sees this group of people as being a group that needs 
to be looked after properly, further upstream, in order to prevent this or 
whether it simply sees it as a problem we need to kind of get rid of… 
(Group 3 - Policy & Commissioning Professionals) 
 
Such perceptions can influence how this group of people engage with services, because they 
have carried on self-medicating with substances or view themselves as undeserving of 
treatment (such as a transplant) compared to others:   
 
I think sometimes it can make people less willing to engage because they 
don’t feel they deserve the service, so they just carry on self-medicating. 
(Group 1 - Frontline HSCP) 
 
In summary, interviewees debated the application of the common definitions of palliative 
care, EoL care, and recovery from substance use to people with substance use problems 
who have EoL concerns.  Interviewees also recognised that it remains difficult to talk about 
death and dying, that views of what constitutes a ‘good death’ may also need to be thought 
about differently, and that societal attitudes to substance use can affect access to care.   
 
3.2.ii  Size and nature of the problem 
The second theme in the ‘wider landscape’ cluster covered the size and nature of the 
problem of co-existing substance use and EoL care needs.  Interviewees talked about the 
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scale of the problem and the characteristics of those with EoL and substance use problems.  
Regarding the scale of the problem, interviewees talked about prevalence and awareness, 
covering national and local prevalence of alcohol and drug use and associated mortality, 
challenges with measuring and reporting prevalence, becoming more aware of the extent of 
the problem, and thoughts on future prevalence. 
 
National and local prevalence  
Overall, interviewees recognised that there had been an increase in both alcohol- and drug-
related deaths, with liver disease deaths particularly highlighted by one interviewee.  
However, as a counter to the majority view of increased prevalence, one interviewee 
thought that liver disease deaths had plateaued in recent years, while another hinted that 
the increase in prevalence might be associated with improvements in reporting rather than 
an actual increase.  A couple of interviewees reflected on the increase in heroin deaths in 
recent years, particularly among younger populations who may be unaware of the heroin 
epidemic of the 1980s and 1990s.  Some interviewees commented on prevalence within 
particular populations, such as deaths in prisons, and deaths among those who had a 
‘deprivation of liberty order’ because of their inability to look after themselves.  One 
interviewee said that this is primarily associated with Alzheimer’s but can also include 
alcohol- and drug-related deaths.  A third interviewee discussed prevalence in terms of 
where deaths occur (with specific reference to alcohol liver disease), commenting that most 
of deaths take place in hospitals rather than hospices.   
 
Several interviewees gave localised examples of prevalence (see Box 1 below).  Their 
examples illustrate geographical and professional diversity.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In talking about prevalence some interviewees thought that official data were just the ‘tip of 
the iceberg’ and did not offer a true reflection of the full extent of the problem:  
 
Box 1 - Local examples of prevalence 
• A ‘High number’ of clients using a service for older drinkers had alcohol liver 
disease.  
• Scoping 6 hospices in one Scottish city – 2-4 patients a month with addiction 
issues and, overall, a significant but not huge number of patients are in their 
20s. 
• Specialist EoL social worker in a major English city - 5-10% of patients at any 
one time have substance use issues – excluding those drinking or using 
cannabis non-problematically. 
• This group of people are commonly seen in bed and breakfast accommodation 
in one English city.  
• One English homelessness charity found that 75% of residents had substance 
use issues.   
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I think probably a bigger issue is knowing that the need is a great deal more 
out there than we ever see and how we reach that is an issue. (Group 3 - 
Policy & Commissioning Professionals) 
 
Some interviewees thought that deaths among an ageing population were also affecting the 
accurate reporting of prevalence:    
 
…we are seeing more people dying while they’re in treatment and those 
aren’t necessarily the people dying of the drug misuse deaths, they are 
people just getting older, iller, frailer, some of the long-term consequences 
of their drug use like Hepatitis C...[and]...smoking. (Group 3 - Policy & 
Commissioning Professionals)  
 
Some interviewees talked about the challenges associated with reporting the prevalence of 
substance use related mortality which generally means that it is under-reported.  Examples 
given by interviewees included: 
 
• Narrow parameters set by the Office for National Statistics (ONS) for measuring the 
prevalence of drug-related deaths, and which do not cover deaths both in and out of 
treatment, or deaths directly or indirectly associated with drugs. 
• Limited categorisation of deaths by coroners as resulting from substance use – for 
example, substances may be named on a death certificate if they have directly 
contributed towards a cause of death (CoD) but not if this is unclear. 
• Decisions made by GPs as to what to put down as the CoD on a death certificate – 
particularly where substances are more indirectly linked to death.  Similarly, under-
reporting by GPs who may not connect CoD with the longer-term history of substance 
use (particularly if the person was not drinking/using when they died).   
• Cancer caused by alcohol – this can be labelled as cancer rather than alcohol-related 
disease. 
• Cases where substance use may be at lower levels/non-problematic, or where someone 
is using cannabis for pain relief or is on methadone substitution therapy. 
• Disconnect between the numbers of people dying of liver disease and the significantly 
lower number who receive a transplant. Overall, many people with liver disease do not 
reach the attention of key professional groups such as hepatologists.   
• Cases where families do not want substances to be named on the death certificate as 
contributing to the cause of death.  
 
Several interviewees thought that there had been growing awareness in recent years about 
people with substance use problems and EoL issues:  
 
I saw it as such a huge area of unmet need... the group that we haven't 
paid that much attention to as an end of life care group, are the people 
who are dying from liver failure. (Group 2 - Senior HSCP) 
…we’ve [hospice] recognised we need to do something about it, which is 
why my boss grabbed me two or three years ago and said, ‘let’s look at 
this’. (Group 1 - Frontline HSCP) 
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A small number of interviewees gave specific examples about the greater recognition being 
afforded to this issue.  For example, one interviewee said that EoL and liver disease had 
been recently included in a British Liver Conference programme for the first time.  Other 
interviewees talked about specific gaps in awareness of EoL issues among people with 
substance use, at both national and local levels.  One person thought that awareness was 
lacking because of a more fundamental lack of attention to EoL among many populations 
who have long-term conditions, including people with substance use problems:  
 
…we’re talking about long-term conditions and the talk never gets to the 
fact that people die, so the talk is always about prevention, self-care, best 
management and I keep having to say, ‘but they will die at some point so 
when are we going to deal with this?’… (Group 3 - Policy & Commissioning 
Professionals) 
 
For three interviewees, they each had an experience with one of their patients that ‘made 
me think’.  As a result, they became more aware of this patient group and the need to 
improve their care:   
 
I presume it was one poor patient who was really struggling, but it made 
you realise that there is a gap in provision there. (Group 1 - Frontline HSCP) 
 
I think my involvement has been less of a planned thing, it’s been based on 
really thinking about someone’s individual experience and how awful that 
was really...it just makes me stop and think, ‘What are we doing about 
that?’, ‘What is anybody doing about that?’. (Group 2 - Senior HSCP) 
 
I’ve niched the market really...we had a patient with addiction issues and 
cancer pain and none of us really knew what to do or how to manage 
her...I realised that it wasn’t just us...it was kind of everyone locally didn’t 
know where to ask for help. (Group 2 - Senior HSCP) 
 
Another interviewee thought that awareness was growing because of the need to 
understand why the UK health and social care system is under so much pressure:   
 
I think the awareness is slowly increasing...because people are looking for 
why is the system under pressure? ...so if suddenly the system pays 
attention to people who are frequently turning up to A&E, these people 
become more obvious so it’s a slightly odd societal attitude (Group 3 - 
Policy & Commissioning Professionals) 
 
Interviewees also gave their views on future prevalence. Generally, interviewees were likely 
to express views that prevalence would increase, partly through changes and trends around 
substance use (the rising problem of the use of novel psychoactive substances [NPS]; Spice 
was particularly mentioned), and wider societal and cultural changes such as the ageing 
population and the closure of pubs:  
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I think in another ten years, we’ll see a different picture, there will be more 
people with more problems, there’s a lot more people with psychological 
problems because life has got tougher for a lot of people and the resources 
aren’t there to help people when they’ve got psychological issues. (Group 1 
- Frontline HSCP) 
 
I think they are going to become a bigger population within the NHS...in 
the next 10-15 years in terms of like the hepatology patients, the head and 
neck, lung cancers and the COPD and all the things that go with that, so I 
think it’s a huge time bomb...they are only going to become a bigger 
number of patients and the problem will become bigger. (Group 2 - Senior 
HSCP) 
 
One interviewee wondered if the purchase of drugs via the ‘dark web’ would influence 
patterns and prevalence of use.  However, some interviewees had more mixed views about 
future prevalence.  Some thought that prevalence in some areas may fall, for example when 
the ‘bulge’ associated with the heroin epidemic of the 1980s-1990s runs its course, although 
the current resurgence in heroin use may cause problems in the future.  One interviewee 
thought any future predictions were difficult to make because of uncertainty around the 
long-term use and problems associated with things like the use of NPS:  
 
I think it probably is too early to say quite what is going to happen with 
younger people going forward because their patterns of use and misuse 
are quite different and still developing, as some of the newer psycho-active 
substances, their harms start to emerge, things that people just hadn’t 
predicted. (Group 3 - Policy & Commissioning Professionals) 
 
Interviewees talked about the impact of increasing prevalence on workload, and of the 
influence that the availability of resources has on the capacity to adequately respond to this 
growing problem. 
 
Client profile and demographics 
Interviewees discussed a number of characteristics of people with EoL and substance use 
issues, including gender, age, substances used, complex presentations and multiple 
morbidities.  Overall, while some broad patterns emerged, interviewees generally thought 
that it was a diverse population which does not meet one consistent pattern or stereotype:   
 
It’s very varied. It is never one group, it’s never one solution. But the 
commonality is that they probably don’t get a very good service, they have 
differing needs. (Group 2 - Senior HSCP) 
 
Interviewees made few clear comments about gender and wider gender identities beyond 
male and female were not mentioned.  For example, one interviewee thought that the 
problems were more common among men while another thought that there were no 
gender differences, and a third commented that homeless women have less entrenched 
problems and are perhaps more likely to have support around them.  
 
21 
 
Interviewees talked more about age and a generally mixed picture emerged.  On the one 
hand, several interviewees commented on the increasing presentation of those in younger 
age groups.  The family said that their relative was 37 when he died, while the service user 
interviewed was in his mid-40s.  Some interviewees commented specifically on the age of 
those dying from alcohol liver disease which one interviewee described as “horrendously 
low”.  Interviewees also commented on younger people presenting with, for example, 
Wernicke-Korsakoff syndrome4, heroin use and COPD5, substance use and Hepatitis C, the 
impact of overdose or intravenous drug use, and the consequences of the use of NPS.  
Further, two interviewees indicated that some care settings (for example, hospices or other 
forms of residential care) can be inappropriate for those in younger age groups including 
where there are serious conditions like Wernicke-Korsakoff syndrome.  
 
On the other hand, interviewees also discussed the characteristics of those in older age 
groups: 
 
…the population is getting older and you’ve got to have that in your 
framework, in terms of working with people. (Group 2 - Senior HSCP) 
 
Two main issues around those in older age groups were discussed.  First, problems in older 
age groups as a result of ageing and age-related conditions, which may be directly or 
indirectly associated with their substance use.  Second, the current ‘bulge’ of deaths as a 
consequence of the drug (heroin) epidemic from the 1980s-1990s.  One interviewee 
commented that the ageing substance use population is a paradoxical outcome of the 
success of substance use treatment.  
 
With regards to substances, there was consensus among interviewees that alcohol tends to 
be the dominant drug in populations of people with EoL and substance use issues.  
However, interviewees also talked about a range of other substances which they saw 
through their work. They listed opiates and heroin, benzodiazepines, cannabis, cocaine, 
ecstasy, prescription medicines, steroids and fentanyl.  Six interviewees commented 
specifically on NPS and problems associated with its increasing use, with one describing it as 
“the absolute drug of choice at the moment”, although one interviewee thought that their 
ban (introduced in May 2016) had led to some improvement:    
 
We don't know very much about [it]...I've been in that many prisons and 
the ambulances are being called four/five/six times a day. It's shocking 
stuff, it's awful...It's going to be a big one. (Group 2 - Senior HSCP) 
 
Oh my word, I can’t tell you, I have never in my life rung 999 so often, it’s 
been really bad. (Group 1 - Frontline HSCP)  
 
Interviewees were clear that substance use and EoL rarely presented in isolation and 
discussed a number of commonly co-existing health and social conditions.  With regards to 
health conditions, cancers, smoking and COPD, and Hepatitis C were most commonly 
                                                     
4 Severe brain damage as a result of long-term and chronic alcoholism.  
5 Chronic Obstructive Pulmonary Disease – an umbrella term for a range of progressive lung diseases often 
associated with smoking.  
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mentioned.  A small number of interviewees mentioned other health conditions; for 
example, heart problems (including the service user who had endocarditis), HIV, and 
pancreatitis.  Interviews talked about many cancers, including lung, gastric, bladder, breast, 
bowel, head, neck, liver, and oesophagus.  Lung, head and neck cancers were the most 
commonly mentioned.  One interviewee thought that cervical cancer was being missed 
because women are often in chaotic situations and do not attend for screening.  There was 
recognition that cancer may be associated with the substance use and its associated lifestyle 
but also a recognition that it may be separate and unrelated to it (although there might be 
increased susceptibility).  Interviewees also commented that cancer diagnoses could often 
come late because of client chaos resulting from their substance use (and possibly also 
other co-existing issues such as mental health problems) and that, as a result, the cancers 
might be quite advanced.    
 
Smoking and COPD, and associated cancers (particularly head, neck and lung) were seen as 
an “increasingly common” problem, particularly among drug users.  One interviewee 
thought that smoking (and hence associated problems) in substance users had been 
overlooked:   
 
There’s been such a focus over decades of drug treatment on treating the 
illicit drugs and just leaving the smoking alone because that’s just too 
difficult and so you help people to recover from their drug misuse, only for 
them to then die of tobacco related disease...it’s kind of taken us a while 
and the treatment system quite a while to realise that that is not really 
acceptable. (Group 3 - Policy & Commissioning Professionals)  
 
Finally, Hepatitis C (associated with both injecting drug use and alcohol use) was also seen 
as an increasing problem, but one that is hard to treat because of the late identification and 
presentation of patients (often despite frequent admissions to hospital) and the complex 
nature of patients (for example, Hepatitis C is common among homeless people). 
 
With regards to social conditions, interviewees highlighted traumatic pasts (particularly a 
history of abuse or being in care), mental health (including disabilities and cognitive 
impairment which may or may not be associated with the substance use), being homeless 
(or residing in a bed and breakfast or hostel), and social deprivation and isolation.  A 
number of other issues were also mentioned, including being a prisoner and bereavement:  
  
There’s a lot of tri-morbidity – physical health, mental health and addiction 
issues – so it’s a very complicated picture for people. (Group 4 – Other 
Professional)  
 
Our client group have a huge complexity of need that needs to be 
addressed and substance use very often comes hand in hand with mental 
health issues, so it’s such a difficult thing to look at in isolation. (Group 1 - 
Frontline HSCP)   
 
Overall, there was some consensus among interviewees about the impact on the delivery of 
care when trying to support those who are presenting with complex and multiple problems.  
23 
 
One interviewed commented on the challenges of care when the system seems to be 
increasingly fragmented.  Interviewees also talked about the challenges of working with a 
group who are isolated, including because they isolate themselves, and disadvantaged:  
  
These people are already disadvantaged in society. (Group 1 - Frontline 
HSCP) 
 
We have people who socially isolate themselves from everyone and 
usually, those people who socially isolate themselves have either got a 
drug or alcohol problem and have been estranged from family members 
for years...[they’re] anonymised and not known to people. (Group 1 - 
Frontline HSCP) 
 
A few interviewees talked about the challenging living conditions of some clients and how 
this can impact on both their engagement with services and on the provision of care in the 
home by professionals: 
 
[They] end up living in dire circumstances with no support to actually look 
after them at their end of life... they don’t even have anybody to go to the 
shop to buy a pint of milk...it’s very dirty, they haven't got anything, they 
haven't even got the basics, some people haven't got a bed. (Group 1 - 
Frontline HSCP) 
 
In summary, interviewees recognised the increasing prevalence of mortality among people 
with problematic substance use, and of the problems seen in recent years with the growing 
use of drugs like novel psychoactive substances.  Interviewees highlighted several common 
characteristics of this group, including their younger age, increasing problems in older 
people often because of co-existing health conditions, and of the multiple physical health, 
mental health, and social issues which many patients present with.  Overall, this is a group 
of people who present many challenges for health and social care professionals.   
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3.2.iii  Commissioning and delivery 
Interviewees discussed two main aspects of commissioning and delivery.  First, the national 
commissioning picture in both substance use and EoL care, and second, how policy issues 
impact on commissioning and practice.   
 
National commissioning picture 
Interviewees talked about the national commissioning of both drug and alcohol services, 
and palliative and EoL care.  With regards to drugs and alcohol, interviewees gave generally 
negative views about commissioning, including the shift from protected to localised 
budgets, the increased frequency of recommissioning cycles, and having integrated drug 
and alcohol services.  At least two interviewees described alcohol commissioning as 
disastrous” and “a complete disaster”.  One interviewee criticised the move to localisation 
while another criticised disintegration and the lack of continuity between services:   
 
Care has shifted to local authorities who maybe have different priorities 
and as their money’s got really, really tight, they’re looking at ways in 
which they can save money, if that means shortening treatment, hastening 
people out, then the story is certainly that that is what’s happening. (Group 
3 - Policy & Commissioning Professionals) 
 
There’s no continuity from the hospital into the community, they’re seen 
as two separate entities and then it’s shopped out to the person that can 
provide it the cheapest in the community...it’s more disjointed now than 
it’s ever been with alcohol...I feel very angry about the way alcohol services 
are being disintegrated...the ‘any willing provider stuff with alcohol might 
work fine if you're booking heart [appointments], CAMHs or something, it 
doesn't work fine for this because it’s far more complicated than that. 
(Group 2 - Senior HSCP) 
 
There was a general sense that alcohol loses out through integrated commissioning as drugs 
are prioritised and differences between alcohol and drugs are insufficiently recognised. One 
interviewee commented that commissioning teams are often smaller and tasked with 
working more generically, meaning that commissioners no longer have adequate specific 
understanding about things like addiction. Some interviewees also felt that addiction is not 
prioritised as a commissioning issue: 
   
Within most local authorities, I don't think addiction is one of those things 
that local authorities would prioritise, there’s no statutory requirement so 
when the pressure is on child protection and vulnerable adults with 
disabilities and all those things, I think this is a service provision that will 
get squeezed even more as well. (Group 2 - Senior HSCP) 
 
I think unless we get commissioners wanting to see this built into service 
specifications, then really we're left with those GPs who are prepared to be 
engaged...So unless we get the pathways commissioned it really is going to 
be about trying to convince GPs to incorporate this client group into their 
current palliative care arrangements. (Group 1 - Frontline HSCP) 
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However, a small number of interviewees gave examples where palliative and EoL care is 
being recognised within drug and alcohol commissioning. For example, some of the bids 
submitted to run one treatment contract mentioned palliative care pathways; EoL care is 
one of five strands of the Pan London health initiative for homeless people; and EoL care is 
being increasingly recognised as a key issue for those with liver failure.  One interviewee 
said that the updated clinical guidelines on drug misuse and dependence will refer more to 
pain management, although someone else said that there is nothing about palliative and 
EoL care in the revised ‘Orange Book’6.  
 
With regards to national commissioning for palliative and EoL care, interviewees said that 
there is no national commissioning (commissioning is led at a local level by Clinical 
Commissioning Groups) and no specialist palliative care commissioning.  There was also a 
sense that commissioning is biased towards pain management rather than broader aspects 
of care.  One interviewee said that the needs of substance users have been recognised but 
that funding constraints means that a national programme of work is not possible, adding 
that there is a need to think more creatively about how to integrate this issue with other 
national programmes of work such as mental health, homelessness and prisoners:  
 
…rather than is there a piece of work for this group of people, it’s how can 
we raise awareness about this sub-group of people within each of those 
other areas?...[we] can only champion so many things...but certainly I think 
substance abuse as a precursor to all kinds of conditions, all kinds of 
diseases, that lead to end stage and death and dying, is an obvious path. 
(Group 3 - Policy & Commissioning Professionals) 
 
Overall, interviewees suggested that substance use policy does not sufficiently address EoL 
care, and vice versa, and that this population needs to be addressed in both areas of policy:   
 
So I do think that there needs to be written within both policy 
frameworks... something specific to this...I think any agenda around liver 
needs to have that in. (Group 2 - Senior HSCP) 
 
Interviewees went on to outline three key, overlapping, challenges that they think are 
greatly affecting national and local commissioning and practice.  Namely, fragmentation, 
inflexibility, and being stretched in terms of both capacity and financial resources.  In talking 
about these challenges, several interviewees made comparisons with how things used to be, 
generally feeling that aspects of practice are not as good as they used to be. For example, 
there used to be more district nurses and hospital Matrons, GPs had lower workloads, 
shared care with GPs in relation to substance misuse was more common, substance use was 
included in local GP contracts, and there were more ‘dry’ hostels. 
 
First, interviewees talked about fragmentation nationally (including geographical variation), 
locally, between sectors and between organisations/services.  At a national level, many 
interviewees felt that there was quite wide geographical variation in commissioning, 
                                                     
6 A Department of Health publication which guides all practitioners across the UK in the treatment of alcohol 
and drug dependence.   
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practice, attitudes and, hence, care. Some interviewees felt that things are often too 
London-centric and not always transferable to other localities.  Variation between London 
boroughs, and between urban and rural areas, was also discussed:   
 
Perhaps an advantage of working in a more localised area is that in a big 
city, you’ve got people that access four, five different hospitals and have 
different networks, we have one mental health team, we have a drug and 
alcohol contact, we share a building with the district nurses so the 
pathways are easier in a way than they are within a big city. (Group 1 - 
Frontline HSCP)  
 
The family described the polar extremes of care that their loved one experienced by two 
different hospitals a few miles apart in the same city.  Other interviewees talked about the 
challenges of operating in a more localised way.  On the one hand it can be harder to 
identify and find out about good practice at a local level while, on the other hand, one 
interviewee felt that a more localised approach can breed, “a growth in creativity, 
innovation, energy...diversity” (Group 3 - Policy & Commissioning Professionals).  However, 
a more common view was to discuss the local impact of national decisions and cuts and the 
resulting fragmentation which many interviewees felt affected commissioning:  
  
Our hospital [has] six separate commissioning groups, all of which have a 
separate alcohol provider, some of which don’t have any at all because 
they’ve not chosen to fund it, none of which are attached to the inpatient 
hospital service that used to coordinate the whole journey through. (Group 
2 - Senior HSCP) 
 
Some interviewees also thought that cuts and fragmentation had increased competitiveness 
rather than collaboration:   
 
Alcohol services do not flow, secondary care and primary care are 
disparate, often competing for the same resources in this any willing 
provider nonsense. (Group 2 - Senior HSCP) 
 
This same interviewee had also experienced a lack of continuity between services, and 
between professionals working for different services:  
 
…no continuity between the two and so, from the person who comes in 
from their acute medical emergency, where they need secondary care 
services, to the community which is going to stop that emergency 
happening again, there’s no link, there’s no thread...it’s all disparate, 
separate services and there’s often not one overseeing physician...and so 
the whole thing becomes just fragmented to the extent that it’s entirely 
ineffective. (Group 2 - Senior HSCP) 
 
We’re no longer in the hospital, again because of recommissioning and 
cuts, so there was a very large hospital team that we had across the four 
general hospitals in [City] and we lost that contract but the current 
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provider of the contract cut an awful lot in terms of finances...there’s a 
notional hospital presence but nothing like before so I guess all those 
pathways and everything that we set up, disappeared...it’s destabilised. 
(Group 2 - Senior HSCP) 
 
Interviewees went on to talk about how a fragmented system affects referrals and care.  For 
example, it brings challenges with sharing information and caseloads, and with offering the 
holistic and person-centred response which can respond to multiple morbidities/ needs: 
 
Multi morbidities seem to be becoming more common so it’s not only 
physical health but mental health and the need to be able to treat all of 
those as people approaching the end of life and the difficulties doing that, 
when services do seem to be increasingly fragmented. (Group 3 - Policy & 
Commissioning Professionals) 
 
Moreover, professional colleagues in the community become more anonymous and 
depersonalised and work more generically than specifically.  It is interesting that the two 
examples below both make comparisons with the past:   
 
The alcohol nurses used to work with us, they used to do clinics next to us 
so we could talk to them and ask them and we both managed the same 
patient that we had a cup of tea and talked about at the end and that’s 
gone now...we’ve lost their expertise, they’ve lost ours, it’s gone to 
someone in the community that I’ve never met, will never meet. (Group 2 - 
Senior HSCP) 
 
We used to have quite small, dedicated district nursing teams...you would 
know your patients inside out and they would be reviewed regularly by the 
district nurse sister with experience and you've now got massive teams 
with less experienced team members and [they’re] even talking not about 
these patients, people go in and you don't know what they don't know so 
they’re not picking up cues and managing things more effectively so you 
will go into see a patient and find that you're picking up problems that you 
thought another health professional should have perhaps seen. (Group 1 - 
Frontline HSCP)  
 
Second, interviewees viewed services as often being inflexible and not set up to ease access 
for these vulnerable and chaotic patients:   
 
A health service that is designed around schedules and appointments, 
don’t necessarily work for people who have more chaotic lifestyles and the 
slack has gone out of the Health Service. (Group 3 - Policy & Commissioning 
Professionals) 
 
Certainly, if you've got somebody who's older and who's a drinker and 
who's got no literacy, what's the point in sending them letters?  They're not 
going to go to those appointments. (Group 2 - Senior HSCP) 
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One interviewee thought that specific initiatives, like payment by results (where a service is 
paid according to targets met or outcomes achieved), breed inflexibility:   
 
…[it’s] a sort of tariff-able intervention...we get the generic letter saying, 
‘patient x has received a 40 minute alcohol-related intervention, they 
didn’t turn up so we’ve not given them another appointment, I hope you 
enjoy seeing them in ITU in two weeks’ time. (Group 2 - Senior HSCP) 
 
Some interviewees talked about inflexibility in terms of differing ways of working between 
professions:   
 
I’ve probably seen about five patients jointly with the hospital addictions 
team and we come at it from a very different...we might have to do this a 
bit differently, they’re still very stuck in their regimented old school. 
(Group 2 - Senior HSCP) 
 
Where you're trying to get organisations to be flexible when they 
themselves are over-run and they have just certain ways of working and 
you need to fit the bill...it can be a real, real challenge. (Group 1 - Frontline 
HSCP) 
 
Third, interviewees felt that the overall system is stretched.   
 
[It]’s a resource issue and it's a staffing issue and it's a time issue and it's a 
needs issue and it's a demands issue… (Group 2 - Senior HSCP)   
 
A small number of interviewees were more optimistic, thinking that their community 
palliative care team, clinical nurse specialists, and aspects of hospital liver care were quite 
well resourced.  One interviewee said that palliative care “pulls on the heart strings” and can 
be “quite marketable”.  However, overall, most interviewees talked more pessimistically 
about an overall lack of resources and the negative impact this has on care:     
 
It’s sad because you're under-resourced for what you do and the end of life 
should be the best and we now have to go with good enough. (Group 1 - 
Frontline HSCP) 
 
We always like to give a gold standard and sometimes you have to accept 
that you need to do a silver standard because you haven't got the time to 
do the gold. (Group 1 - Frontline HSCP) 
 
The difficulty is, that none of us have got the resources that we need to 
best meet the needs and to quickly meet the needs to save going round 
and round in circles...If the provision was there in the first place it should 
be straight line A to B job done.  But because provision isn't there we just 
have the chaos that we do. (Group 2 - Senior HSCP) 
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One interviewee felt that the group of patients they were talking about (homeless/ 
substance use) are just not popular and so do not attract resources: 
  
When resources are tight, him who shouts loudest gets heard, this group of 
people don’t shout in terms of ‘Look after me’.  (Group 1 - Frontline HSCP) 
 
Interviewees also thought that there was a bias towards London when allocating resources, 
but also that substance use and EoL care are competing for resources with a number of 
other areas (many of which overlap with substance use and EOL), including mental health, 
prisons and housing.  Overall, interviewees talked about several ways in which they felt 
things were stretched. These included increased competition for smaller budgets, 
recommissioning, being asked to make resources stretch further, lack of pooled budget 
arrangements, less ability to focus on prevention and early intervention but “firefighting” 
and working reactively, the move to community focused care, and the reduction in aspects 
of care such as specialist palliative care nurses and district nurses.  Such restrictions can 
impact upon waiting lists, hospice beds, access to housing, and a care market which one 
interviewee described as “collapsing”.  One interviewee described a liver clinic as stretched 
and wondered what would happen if the patients who are currently not seen (for example, 
because they have not been identified or they do not attend) also started attending such 
clinics.   
 
Policy impact on commissioning and practice 
Interviewees highlighted several policy directives which they felt affected both national and 
local commissioning and led to challenges for practice.  Namely, policy agendas that are too 
mainstream and cancer focused; the need for integrated and/or specialist commissioning; 
and debates as to whether care should be centralised or community focused.  In practice, 
they identified the need for dedicated roles, services and champions; a lack of local 
direction and guidance in how to work when the two issues overlap; and gaps in workforce 
development.   
 
First, some interviewees felt that palliative and EoL care is still overly oriented towards 
mainstream issues such as cancer:   
 
I do think at the moment the end of life agenda is very dominated by the 
mainstream. (Group 3 - Policy & Commissioning Professionals) 
 
One interviewee said that, as something of an experiment, they gave a group of 
hepatologists two case scenarios of patients with end stage liver disease, one of whom had 
a better prognosis despite also having cancer.  Despite the prognosis being worse in the 
non-cancer patient, a referral to palliative care was approximately twice as likely with the 
cancer patient.  This interviewee further commented on the dearth of referrals of people 
with liver disease to hospice care:    
The fact is it’s the third commonest cause of death in working age adults 
and you go to a hospice and no-one’s ever seen liver disease, [it] is a real 
indictment of the state we’re in with it. (Group 2 - Senior HSCP) 
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However, another interviewee, talking about hospice care, felt that there was a shift 
towards engaging more with groups of patients who do not have cancer:   
 
I’ve actually found that hospices are the most understanding...but I think 
although it is generally overrun with cancer, more and more I think that is 
shifting which is really great to see. (Group 1 - Frontline HSCP) 
 
Second, interviewees talked about the need for integrated and/or specialist 
commissioning.  They felt that this would tackle identified problems with the lack of 
continuity between hospital and community; problems with integrated alcohol and drug 
treatment services; the lack of integration between substance use and palliative and EoL 
care; the need for better integration with GPs; and the fragmentation between health and 
social care: 
 
I think unless we get commissioners wanting to see this built into service 
specifications, then really we're left with those GPs who are prepared to be 
engaged...so unless we get the pathways commissioned it really is going to 
be about trying to convince GPs to incorporate this client group into their 
current palliative care arrangements. (Group 1 - Frontline HSCP) 
 
So what it needs is for health and local authority commissioners to be 
working together, to ensure that there are the pathways to the services 
they can help with those broader physical and mental health problems that 
drug treatment services are in an ideal place to scream for and to support 
and to refer onto and to support people to, but can’t actually do 
themselves. (Group 1 - Frontline HSCP) 
 
Some of the specialist, partnership, services that interviewees talked about can only happen 
if there is integrated commissioning:  
 
We need a hostel type environment that has the expertise and the 
resources of a hospice...that’s not going to be achieved unless we have 
integrated commissioning from Health and Housing and Social Care. (Group 
4 – Other Professional)   
  
Third, interviewees talked about centralised or community focused care.  There were views 
in favour of each approach:  
 
The cuts have meant that we spent all the years moving out to a 
community based model and it’s now shifting back to more of a centralised 
model, so I think it then reduces those opportunities [to engage with 
clients and build trust]. (Group 2 - Senior HSCP) 
 
There’s a massive push nationally for people to be looked after at home, 
get away from acute settings and there’s a lot more targets being set in the 
community, without the funding. (Group 1 - Frontline HSCP) 
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A number of interviewees saw potential in moving services to a range of community settings 
such as homeless hostels, needle exchange or job centres: 
 
I haven't got any evidence to back any of this stuff up but I have got 
evidence that my patients don’t turn up to clinic after I’ve seen them in 
hospital, the next time I see them is when they come in vomiting blood to 
A&E. (Group 2 - Senior HSCP)  
 
However, there are also challenges with community focused care which overlap with the 
issues of fragmentation, inflexibility and resources discussed above.  There needs to be 
careful decisions about what can and cannot be delivered in a community setting.   
 
In terms of practice implications, interviewees highlighted the need for dedicated roles, 
services and champions.  Some interviewees commented on the positive impact of 
specialist roles such as a palliative care coordinator for homeless people, the only such role 
anywhere in the UK, and multi-disciplinary pathway teams in hospitals which can develop 
holistic care packages for homeless people.  Such roles can bring much needed time, 
expertise and dedication: 
 
To hear the impact that she’s had for staff compared to people that don’t 
have that service has been very striking...initiatives like that that are much 
more person-centred and are kind of advocating for homeless people in 
those settings, so that people feel that they have someone on their side 
when they go in... a phenomenal initiative which I think is also shown really 
good benefits. (Group 4 - Other) 
 
Examples of other specialist services or roles suggested by interviewees included specialist 
support within prisons, outreach or inreach from hospices to hostels, hospices beds in 
hostels, and specialised services for homeless people or those with substance use issues.  
The family said that they would like to see specific hospital wards for people with alcohol 
problems (for example, for draining), and for specialist facilities so this can be done on an 
outpatient basis.  
 
Next, interviewees talked about the need for more local direction and guidance when the 
two issues of substance use and EoL overlap. Several interviewees held the view that there 
was an overall lack of guidance, particularly at a local level, for caring for this group of 
people including around specific issues such as prescribing and pain management.  One 
interviewee, a specialist EoL social worker, said that there was no guidance on joint working 
with drug treatment services. The family felt there was a need for hospital ward staff to be 
trained in how to care for people with substance-related conditions such as liver failure.  
One interviewee said that they set up a multi-disciplinary working group to see if they could 
develop local guidelines or a group of interested skilled professionals so, “that if we didn’t 
know what to do, we could at least ask somebody ‘what would you do’?” (Group 2 - Senior 
HSCP).  Another interviewee suggested the need for some kind of policy hub or coordinator 
to pull everything together for ease of access, while another commented on the dissolution 
of national organisations like Drugscope and Alcohol Concern and the loss to the sector as a 
result of the information, expertise and training functions that they provided.  Finally, one 
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interviewee suggested that there was a need for greater involvement of ‘people with lived 
experience’ in developing responses and care:     
 
We create solutions and we often are very good at co-designing solutions 
but we’re also used to co-designing solutions with people who think they 
know what the problem is rather than with people themselves. (Group 3 - 
Policy & Commissioning Professionals) 
 
Finally, some interviewees talked about gaps in workforce development.  Overall, 
interviewees thought that there was a need for more training in working with this group of 
people.  Further, each profession needs to receive training that best meets identified gaps – 
for example training those in the substance use sector to work with people with EoL care 
needs.  Training needs to cover a range of things including identification and asking 
questions, planning and talking about care, getting to know the patient to deliver a person-
centred response, and issues around management of medication including alongside any 
ongoing substance use.  Another area for workforce development is around the 
development of pathways to encourage and facilitate collaborative working, and guidelines 
to support care.  The family felt the need for hospital staff to be better trained because 
there were aspects of their relative’s clinical care that they felt were poorly managed:   
 
The staff there need training in people skills for one, that would be a 
massive thing for them, they need training in how to deal with 
bereavement because I don't think they’ve got a clue, sympathy and 
empathy and the whole, ‘we know how you feel’, ‘no you don’t because 
this is just another number to you’. They shouldn't ever, in my opinion, 
turn around and say, ‘We know how you feel’ because you don’t. (Family) 
 
In summary, interviewees had a generally negative view of the commissioning of both 
substance use treatment services, and palliative and EoL care services, and of the impact 
this has on delivering care to people with substance use and EoL concerns.  Overall, 
interviewees suggested that substance use policy does not sufficiently address EoL care, and 
vice versa, and that this population needs to be addressed in both areas of policy.  
Interviewees outlined a number of key, overlapping, challenges that they think are greatly 
affecting national and local commissioning and practice, namely: fragmentation; inflexibility; 
being stretched in terms of both capacity and financial resources; agendas that are too 
mainstream and cancer focused; the need for dedicated roles, services and champions; the 
need for integrated and/or specialist commissioning; debates as to whether care should be 
centralised or community focused; a lack of local direction and guidance; and workforce 
development.   
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3.3  Thematic Cluster 2: Engaging and Responding 
The second thematic cluster was entitled ‘engaging and responding’, and this covered four 
broad themes - engaging clients; managing and developing care responses; (not) talking 
about substance use or death and dying; and families and networks (Figure 4).  
 
Figure 4: Thematic Cluster 1 - Engaging and Responding 
 
3.3.i  Engaging clients 
This theme covers two areas, namely identification of clients (covering screening, 
assessment and referrals) and barriers to engagement.   
 
Identification of clients 
Interviewees talked about the identification of clients’ substance use problems, and the 
identification of other problems (such as cancer and COPD) which may or may not be 
associated with the substance use, as well as the identification of EoL itself.  Some 
interviewees suggested that the focus on other problems and illnesses can mean that issues 
related to the substance use are missed.  Late identification can affect care and 
communication, including because of impaired or limited capacity associated with the 
circumstances of some people when an EoL diagnosis is given (for example, because of 
alcohol-related brain damage).  Additionally, a small number of interviewees indicated that 
in some cases referrals are not made (and hence identification does not happen) because 
professionals are “just simply not thinking about it”.  One interviewee explained how their 
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discussions with a local hospice, supported by reciprocal training, led to both sides 
recognising just such a gap:   
 
When we were starting the conversations with two key hospices, they 
went ‘oh, I never thought about that’...but similarly, I think some of our 
staff went, ‘never thought about palliative care’ either, so there was that 
‘ooh’ moment, realising we haven't thought about this. (Group 2 - Senior 
HSCP) 
 
Interviewees talked about the challenges they faced in asking clients about substance use or 
EOL.  For example, interviewees from palliative or EoL care professions expressed their 
discomfort with asking about substance use, with one saying that they do not feel 
“competent” to ask about such issues and have concerns that it will disrupt patient 
relationships:   
 
We’re already happy to talk about death and dying and your plans and how 
you might die...we can talk about that all day long and not be upset about 
raising those questions with patients but yet I’d probably have palpitations 
...asking, ‘have you been injecting heroin again or what have you been 
drinking?’ (Group 2 - Senior HSCP) 
 
Having information about substance use included in a referral can make such conversations 
easier.  This makes identification simpler because someone already comes with “that label” 
or it emerges through the conversations which accompany a referral, although it was 
acknowledged that time is often needed to build trust for such conversations to be had and 
for honest disclosures to be made.  Two interviewees highlighted the importance of open 
and honest dialogue with clients; for example, emphasising to a client the need for honesty 
to assess and make decisions around prescribing for pain control.  Other interviewees talked 
about knowledge of caseloads providing opportunities for identification, including an 
awareness of “red flags” (such as someone who says that they go to the pub every day) 
when talking to clients.  The role of “intuition” and “gut feelings” was also mentioned.   
 
Interviewees talked about things which made identification difficult, including uncertain 
illness trajectories (such as alcohol liver disease); the possible masking of symptoms; the 
crisis, chaos and complexity which can often accompany this group of people; patients 
moving areas or being homeless; social isolation; denial; and not engaging with services:   
 
Thinking of a chap last year, he was just about at death’s door...he was just 
used to not turning up to appointments and defaulting and didn’t want to 
go for tests or investigations, so they will have poorer outcomes. (Group 1 - 
Frontline HSCP) 
 
There are also issues around, I guess, compliance with treatments, turning 
up to treatments, a more chaotic lifestyle inevitably means that things will 
get missed. (Group 3 - Policy & Commissioning Professionals) 
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Furthermore, interviewees suggested that professional attitudes towards people with 
substance use problems can also hamper timely identification.  Overall, it seems that 
opportunities (often multiple opportunities over long periods of time) for identification of 
EoL conditions in this patient group are missed and then often happen very late:  
 
I think they are hugely disserviced...they present frequently, they’re not 
listened to, they’re diagnosed late...I think they’re often not heard, they 
present often. (Group 2 - Senior HSCP) 
 
A few interviewees suggested that the chaos, denial and difficulties people have in engaging 
with services means that their needs are not identified through primary care routes or 
community services, but through (often frequent) admissions to emergency departments.  
One interviewee said that the frequency of such emergency admissions should trigger 
opportunities to improve identification of EoL and start conversations with people about 
their care. However, even when individuals are in frequent contact with services, 
opportunities for engagement are still missed and interviewees cited several reasons for this 
including a narrow focus and attitudes, such as one interviewee who talked about a man 
who was misdiagnosed for eight years because he was viewed as a “malingerer”:    
 
Sometimes that contact is wasted...an opportunity to deliver quite a 
number of interventions...The people who had seen him had put the ‘it's a 
drug problem’ head on, rather than ‘I am a GP, this is a person’ head. 
(Group 1 - Frontline HSCP)  
 
They see all kinds of hospital doctors, they see all kind of substance abuse 
clinics, why are we not getting referrals from them? (Group 3 - Policy & 
Commissioning Professionals) 
 
The family key informants said it took a number of years, multiple symptoms, and a high 
number of GP and hospital appointments and admissions, before the severity of their loved 
one’s condition was recognised:  
 
There was a few times where we had to go to the doctor’s 'cause he’d be 
complaining that he was passing fluid from his back passage and this went 
on for three or four years didn’t it?...he was in that much pain...we got to a 
point where he did start to deteriorate and we noticed he was [be]coming 
ill...nothing was diagnosed for sure...and then we noticed the yellowing of 
his skin and his eyes and this was where he kept saying, ‘I feel so 
terrible’...he was always complaining he’d got back pain...his stomach was 
out there. (Family) 
 
The masking or misdiagnosis of symptoms can present further missed opportunities for 
identification.  For example, one interviewee drew parallels between the symptoms of ‘cold 
turkey’ (i.e. the abrupt cessation of substance use, usually with no medication to aid 
withdrawal) and peritonitis (inflammation of the tissues that line the abdomen wall) 
meaning that one can easily be mistaken for the other.   
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With regards to alcohol-related liver disease, the unpredictable trajectory of the illness 
(which can last many years) can make identification of the illness, and when it becomes EOL, 
extremely difficult:  
 
He went nearly a whole month and everybody thought he was fine...and 
overnight, something happened because he was in here on the settee and 
he was screaming with pain...he was crying. (Family) 
 
You can have somebody who actually is deemed palliative or at very end of 
life and they’ll leave the hostel and be admitted to hospital, everybody has 
been told they’re going to die and then they come back in a couple of days’ 
time good as new almost, just about and they’re here for another five 
years. (Group 1 - Frontline HSCP) 
 
[The] fluctuating nature of the symptoms and the illness [of liver 
disease]...and it’s identifying at what point should palliative care get 
involved. (Group 4 – Other Professional) 
 
One interviewee explained the challenges with identifying EoL in people with liver disease 
compared with other conditions such as cancers, adding that there are similar challenges in 
predicting terminal illness in people with Hepatitis C or who are injecting drug users:  
 
The trajectory of death in liver disease is inherently unpredictable...I'm 
speaking simplistically but in metastatic solid organ cancers...you will have 
this progression of disease and you can plan the end of life with a degree of 
certainty. With liver disease...the trajectory is very unclear...the period to 
death is very sudden so it’s not like a slow decline...So the steady decline 
that you see in malignancy, which is where palliative and end of life care 
developed as a specialty, and a lot of the evidence base around that, is not 
there in liver disease. (Group 2 - Senior HSCP)  
 
One interviewee talked about the ‘green gap’ of the Gold Standard Framework for end of 
life care7, saying that this is often the hardest ‘group’ to identify but is where those with 
substance misuse and EoL issues might best fit:   
 
In days gone by it used to be the last year of life but these days it’s a little 
bit extended because we don't know what people’s last year of life is 
because of treatments these days...the bit that has to be missing is the 
Green bit...where there’s actually very few people involved in the patient’s 
care in that section and that is probably the harder part of trying to look 
after people. (Group 1 - Frontline HSCP) 
 
                                                     
7 The National Gold Standards Framework (GSF) Centre in End of Life Care is the UK’s leading provider of 
training in end of life care. The GSF employs a PIG (Prognostic Indicator Guidance) with a ‘traffic light’ system 
for the identification of EoL – red is when someone is in the final days of life; yellow is when someone is in 
deteriorating health and may have weeks left; and green is when someone is unstable and in advanced poor 
health with possibly months left. See http://www.goldstandardsframework.org.uk/  
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Interviewees talked about how identification can be affected by referral processes.  One 
interviewee said that a hospital was reluctant to make a referral to a hospice because they 
viewed a hospice as “where you go to die”; another said that a local service for mental 
health and substance misuse would initially not accept referrals from a hospice clinical nurse 
specialist; and a specialist EoL social worker was banned by one hospice from making 
referrals because the hospice seemed judgmental about the clients being referred.  Another 
interviewee felt that a segregated system affected referrals to EoL care for people with 
problematic substance use and subsequently the identification of clients:   
 
The hospital is very good at referring to the addictions team and they’re 
very good at referring to the palliative care service but I’ve yet [to] find that 
a patient that they refer to both services...it’s very segregated...I think 
people focus on one issue. (Group 2 - Senior HSCP) 
 
Barriers to engagement 
Interviewees talked about how professionals can perceive this group of people, and about 
the barriers which clients can experience in accessing services.  Both can impact upon 
identification and care.  Overall, client engagement can be influenced by stigma, which can 
have many forms, and practical access to services.  Interviewees also made suggestions 
about what can facilitate engagement.  One barrier to engagement is around whether 
people can or should continue to use substances at the end of their lives.  
 
Stigma  
Interviewees talked about stigma, both actual and perceived, experienced by this group of 
people, explaining how this can negatively influence client engagement with services:   
 
I think [stigma] is a significant barrier...stigmatised people often behave in 
a stigmatising way because of that, they carry the label. (Group 1 - 
Frontline HSCP) 
 
Stigmatising experiences and attitudes, whether they are direct or perceived, can mean that 
clients are invisible to services (and hence to EoL care).  They can be viewed as difficult, 
unpopular and non-compliant, perceived and treated differently and often with a lesser 
priority than most other groups of patients.  They can also be considered a nuisance 
because of the demands that they place on services, and viewed narrowly in terms of their 
alcohol or drug problem.  Many interviewees talked about these barriers and how they 
ultimately mean that this group of people “get a less good service” through not being 
afforded the same amount and quality of care as is given to others such as those with 
cancer: 
 
Our system works for the vast majority of average people, we’re not 
dealing with average people here and the system is failing them. (Group 1 - 
Frontline HSCP) 
 
We need to be developing services for that, provide the same level of care 
around end of life for people with drug and alcohol problems than it would 
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if they were dying from anything else...everybody deserves as good a death 
as we can help them to have. (Group 1 - Frontline HSCP) 
 
I think they're left to fall through the net to be quite honest because it's 
easier. (Group 2 - Senior HSCP) 
 
Interviewees gave examples of how they, or clients they had known, had experienced 
stigma.  These included: 
 
• Interviewees who said that patients (and their families) can be rude and aggressive, 
misbehave and not conform to the rules of a service like a hospice, which can mean 
that professionals then expect such behaviour from all families;  
• A man whose illness was not diagnosed for several years because he was seen as a 
malingerer (by which time it was too late);  
• The service user wondering if his late diagnosis of a groin abscess was because a 
hospital professional “hated junkies”; and  
• The family who said that their relative talked about sensing that one of the nurses 
did not like him because he was a problem drinker.   
 
One interviewee said that some patients can feel that they are less deserving of a liver 
transplant compared with other people, a view echoed by the service user who wondered if 
he had been refused a transplant because of his known history of drug use.  
 
Service user: It was sort of insinuated that it was through my drug use 
that I’d contracted [endocarditis] [an inflammation of the valves or inner 
lining of the heart].   
Interviewer: Are you saying you think that one of the grounds for 
refusing you [a transplant] might have been a judgment on your drug use? 
Service user: I think it would have been the drug use, yes. 
 
It is interesting that this service user then goes on to say that he understands why he might 
have been refused a transplant:  
 
When you look at some people, how straight they toe the line when 
they’ve been told that there’s the possibility of a transplant, they live 
squeaky clean lives, they do everything that’s asked of them and if it was 
due to my drug use that I damaged my heart, then...it sounds a bit blasé, 
but it was my own fault. (Service user) 
 
It was commonly expressed across the interviews that experiences and attitudes, including 
of the patient group towards themselves, can leave patients feeling that they are not 
worthy of care, or the same level of care that is afforded to others, and are often deeply 
mistrusting and suspicious of professionals:   
 
I do believe the people that maybe are born with congenital heart 
problems that wait for years for a matching hearts or for young children, 
who are innocent, they’ve done nothing wrong and then I go and screw 
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things up by...but it shouldn't be at the cost  of somebody who’s not 
making mistakes, to their detriment, that they get told, ‘we did have a 
heart for you but we’ve given it to this guy that we’re not even sure is 
going to look after it’.  (Service user) 
 
Experiences or perceptions of stigma can reinforce clients’ feelings of hopelessness, low 
self-esteem, guilt, blame and denial.  Some also feel that they do not want to bother 
professionals by asking for help, or are used to looking after and relying on themselves:   
 
A number of these people are actually absolutely lovely and are scared, it’s 
like because they’ve never been overly loved, they think they deserve 
nothing and so they don’t like putting on people.  It’s not just about ‘I don’t 
want to go into hospital’, it’s also ‘I don’t want to mither [bother] them’, I 
can’t tell you how many times I’ve heard this person say, ‘You’ve done too 
much’. (Group 1 - Frontline HSCP) 
 
There was also recognition that some people are so immersed in their addiction and 
concerns over where their next drink, or hit, is coming from that this takes priority over 
everything else. Equally, interviewees felt that some professionals think that there is 
nothing that they can do for this group of people. In some cases, this is borne out of 
experience of a ‘revolving door’ patient who has ignored repeat requests to stop drinking or 
taking drugs: 
 
It can be very exasperating to work very hard on a patient, to get them 
through an [intensive care] stay, through a lot of complex procedures to 
stop them bleeding from the GI [gastrointestinal] tract, have this discussion 
saying, ‘If you go back to drinking, this is going to happen again and the 
next time we might not be able to save you’ and then to see them two 
weeks later, that can be very difficult for the clinician not to be really angry 
with the individual. (Group 2 - Senior HSCP) 
 
 The impact of this is that professionals can take a very narrow focus of patient care:   
 
I think drugs and alcohol users are an easy target to blame, they don’t get 
much sympathy and no-one seems to look at why people are taking drug 
and alcohol...and it’s just hard to shift that out of anyone. (Group 1 - 
Frontline HSCP) 
 
Sometimes it can be difficult to like these people, very honestly, but it is 
really important to look past that and look at the reasons why that person 
is acting in that way. (Group 1 - Frontline HSCP)  
 
Similarly, some professionals may be less inclined to proactively introduce conversations 
about palliative or EoL care:  
 
When somebody is in liver failure, even though they're told, ‘You are in 
liver failure, if you don’t stop drinking, you will die’, they rarely go onto say, 
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‘Right, let’s assume that you're not going to stop drinking, then let’s look at 
that and then I can refer you to the hospice, I can refer you to a counsellor, 
I can refer you to other things’ like you and I would access (Group 1 - 
Frontline HSCP)  
 
Practical access to services 
Interviewees listed a number of practical barriers which can impede clients from vulnerable 
and chaotic groups (such as those with substance use issues) engaging with services 
including EoL care.  These included: 
• Rigid structure of schedules and appointments. 
• Literacy problems which can affect reading letters or paperwork. 
• Practical and financial issues in physically getting to services that expect clients to go 
to them.  
• Waiting lists and times.   
• Social isolation, including people who may not have a next of kin.   
• Issues to do with prescribing and substance use e.g. being maintained on 
methadone, being placed in a wet hostel, ex-users not wanting to be prescribed 
opioids, services that have a zero tolerance substance use policy.  
• Having to keep on telling professionals the same thing because of poor information 
sharing and co-working. 
• Multiple carers meaning that carers do not know or understand a patient. 
• Cognitive impairment (e.g. associated with alcohol use).   
 
The circumstances in which some people live can also greatly influence their access to 
services and make the provision of EoL care in the home particularly challenging:   
 
[They] have chosen that lifestyle, they don’t want to move away from that 
lifestyle and don’t want support and then they get to the stage where they 
can’t look after themselves, we then have to see if we can try and get them 
to accept support from around...But you find generally those that are like 
that, they do not have even a next of kin, a lot of them won’t give you a 
telephone number, contact details of anybody for you to access help... 
(Group 1 - Frontline HSCP) 
 
The fragmentation of services discussed earlier can also affect access to, and engagement 
with, services.  Overall, interviewees thought that services are not set-up to meet the needs 
of groups like this and that services need to be more available and accessible.  However, 
current pressures on the system are barriers to change taking place.   
 
We often talk about ‘hard to reach’ patient groups, but generally it's ‘hard 
to access’ services that have a problem. Because hard to reach means they 
don’t really want to be...we need to make services available. (Group 1 - 
Frontline HSCP) 
 
The slack has gone out of the Health Service... I just have the sense that our 
system is under so much pressure, that I suspect a lot of people are just 
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falling through the net because people are just forgetting they’re there. 
(Group 3 - Policy & Commissioning Professionals) 
 
Facilitating engagement 
Interviewees identified what they thought could facilitate engagement, in addition to 
overcoming some of the practical barriers to access that were outlined above and 
incorporating substance use into care where desired.  Overall, some interviewees identified 
a change in attitude as key, covering both how patients are viewed but also more 
conceptually how addiction is viewed:   
 
I think it’s once they know that they’re not judged, they’re actually looked 
after, they’re given a nice wash, a nice bath, a nice dinner, are able to be 
wheeled outside and go and have a cigarette, that they’ll have alcohol on 
their prescription and nobody is going to stop that when they're here, so 
because that is allowed and not judged, they become compliant because 
they’re quite often at home thinking that everyone is trying to take over. 
(Group 1 - Frontline HSCP) 
 
I think you really need to take away this implicit guilt...the amount of times 
you go onto medical admissions units and the sickest patient on the ward is 
the one with liver failure and they’re the ones the nurses shrug their 
shoulders at because...’they were in last week, we worked bloody hard to 
get them better, they’ve just done it to themselves’, and I personally think 
we treat alcohol as...a sort of implicit, something wrong with the individual 
and something wrong with their character and something morally corrupt, 
as opposed to addiction being part of the pathology in the same way your 
encephalopathy is part of the pathology, or your renal failure is part of the 
pathology. (Group 2 - Senior HSCP) 
 
The service user KI gave two examples of strategies that he employs when engaging with 
professionals, and which he feels has influenced how he is perceived and the care he 
receives from hospice and hospital staff.  The two strategies that he describes are not 
talking about his substance use, and ensuring that he is polite to and respectful of hospital 
staff:   
 
Maybe there’s only one or two people that know about my background 
here. So as far as everybody else is concerned, I'm [Luke8] and I’ve got a 
knackered heart not “Hi, I'm [Luke], I’ve got a knackered heart and I'm a 
recovering heroin addict...my heart thing is why I'm here, I'm not here for 
my substance abuse, I go somewhere else and I get treatment for 
that...they don’t need to know about it, it’s not their business, they’re not 
qualified and they don’t have much to offer me in the way of assistance...It 
could only be detrimental for me to bring it up or make other people aware 
of it, especially other patients. (Service user) 
 
                                                     
8 Name has been changed.  
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I’ve pretty much been of the school of thought that you get treated how 
you treat people, when I’ve been in hospital....I'm always polite, I don’t 
make demands… because you will get treated like shit if you talk to people 
like shit....No matter how much they’re trained and how much it’s meant 
to be healthcare professionals, you can only push people so far and I think 
a select few ruin it for people like, not necessarily ruin it but it creates a 
stigma that affects people like me, they presume a stereotyped behaviour 
pattern. (Service user) 
 
In summary, interviewees talked about numerous challenges in the timely identification of 
EoL in people with substance use problems, and the barriers which many people can 
experience in accessing services.  Related to this, interviewees, particularly those working in 
the substance use sector, discussed how hard it can be to ask questions that might lead to 
improved identification.  Engagement is greatly influenced by stigma, which can have many 
forms, practical access to services, and whether services support people to continue to use 
substances while they are receiving EoL care.  Interviewees made suggestions about what 
can facilitate engagement, including building trusted relationships with people, to make 
difficult questions and conversations possible.   
 
3.3.ii  Managing and developing care responses 
The second theme in this cluster contains four issues on the theme of managing and 
developing care responses.  These are: the importance of a person-centred approach; 
joined-up working; pain and symptom management, and care settings.   
 
Person-centred approach 
Interviewees talked about the important components of a person-centred approach to care, 
as well as how care is planned and managed, particularly when dealing with risky and often 
uncertain conditions.  The key components of a person-centred approach identified by 
interviewees were positive relationships, holistic care, accessible and flexible care, 
communication, and the provision of personal care.  Overall, interviewees advocated for 
putting the patient at the centre of their care, and for doing this in a way which is 
comparable with how people with other conditions are supported: 
 
[We need] to listen to what people actually want rather than push what we 
think they might need. (Group 4 – Other Professional)  
 
It doesn't matter what you do, whether this is self brought on, whether the 
fact you've been a drinker has brought this problem to you, it doesn't 
matter, everybody should be treated equally within their rights so what 
they should have done with [our relative] would have been to have give 
him the treatment he required in the proper way it was required. (Family) 
 
Interviewees also identified the importance of integrating client wishes around their 
substance use into a person-centred approach to care: 
 
…letting them know you do care about them and you do want to just help 
them live....and let them know that ‘we do not want to take you away from 
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this situation at this moment in time, we don’t want you to stop drinking, 
we don’t want you to stop living your life how you have always lived it’. 
(Group 1 - Frontline HSCP) 
 
One interviewee who worked in the homeless sector gave an example of care that includes 
multi-disciplinary case reviews which also involve the homeless person themselves:  
 
[We ask] the homeless person to identify who’s important and who needs 
to be there because it’s trying to engage people in that kind of discussion, 
when often they don’t really want to, you're doing what you can with the 
homeless person and then working around and getting everybody involved. 
(Group 4 – Other Professional) 
 
In one case peer navigators were involved to support homeless people.  However, some 
interviewees acknowledged that person-centred care was not always the reality.  For 
example, one interviewee thought that the recovery agenda that dominates substance use 
treatment runs contradictory to the key principles of person-centred EoL care.  
 
The way that services are judged to be successful is on whether or not 
people recover and that doesn't really take into account...the wishes of an 
individual. (Group 4 - Other) 
 
Perhaps fundamental to a person-centred approach is the relationship between patient 
and professional.  Interviewees talked about the importance of being non-judgmental and 
listening to a person’s experiences and wishes, to build a trusting relationship.  The 
importance of this, and the time that it can take, was acknowledged with a vulnerable group 
of people who may have had very different experiences of services in the past such as being 
dismissed and not heard: 
 
We break the barrier quite often...because we sit down in a dirty house 
and don’t actually judge them on how they are living, they know eventually 
we want to help them, so you do break down some of those hard 
exteriors...we are probably the first people that they’ve met that haven't 
judged them. (Group 1 - Frontline HSCP) 
 
I think patients, when they realise that you're not going to condemn them 
or give them advice to give up, then start trusting you about what other 
things that they’re doing or taking or want to try. (Group 1 - Frontline 
HSCP) 
 
It is so much about engagement, it is so much about trust-building, so the 
people who have been drinking for years and may never have sought any 
help or may have had quite harsh kind of response from their GP or 
medics, it does take them time to trust and quite often by the time people 
come to us, they have very low esteem. (Group 2 - Senior HSCP)  
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Another important aspect of the relationship between professional and patient is facilitating 
reciprocal honesty.  Professionals need to be open with the questions they are asking of 
patients (for example, relating to decision making around prescribing for symptom and pain 
management which is often of great concern for people because of their historic or current 
substance use) and what is and is not possible regarding care.: 
 
We seem to be able to build relationships with these types of patients that 
are not overly honest people...they do seem to show some honesty in the 
end, we ask them direct questions. (Group 1 - Frontline HSCP) 
 
Equally, patients need to be honest with professionals to maximise the quality of care they 
receive.  Some interviewees suggested that EoL can facilitate honesty from patients that 
might not have been present before.  For example, allowing conversations where someone 
may wish to talk about the guilt and regret they feel. 
 
Also, central to a person-centred approach is thinking and working holistically, and offering 
a package of care which responds in the right way to what are often complex and vulnerable 
situations.  Interviewees talked about holistic care in terms of both understanding a 
person’s ‘back story’ and what has brought them to where they are now, and accounting for 
broader health and social needs:   
 
So then you get to see people as whole people don’t you?  Not just 
someone that’s stopped treatment and therefore they’re okay, they don’t 
need to come back, we were then offering people something else that they 
could then come to, so you get to learn more about what goes on for them 
really. (Group 2 - Senior HSCP) 
 
There might be a lot of reasons why they’re drinking and without 
addressing the underlying reasons, to expect someone to stop using 
substances and have no support to deal with what’s underneath that, 
seems unreasonable to me but at the same time, you need to give people 
the chance to stop if that’s what they want. (Group 2 - Senior HSCP) 
 
Interviewees highlighted the need for services to be accessible and flexible, both in 
practical terms (in terms of barriers and in terms of working with people who are actively 
using substances, both discussed elsewhere) and in a way which facilitates engagement and 
the delivery of a more personal approach: 
 
A significant change for [us], from a very much centre-based model 
focusing on that one to one session, to one which was community-based, 
visiting people at home...we didn’t have a really prescriptive way of how 
we were going to do it...we discovered different people with different 
needs and realising that we’d done an all right service but perhaps we 
could do a much, much better service. (Group 2 - Senior HSCP) 
 
As part of this, interviewees emphasised that work like this requires more time:  
 
45 
 
We can’t seem to cope with the fact that people with complex problems 
need more time. (Group 3 - Policy & Commissioning Professionals) 
 
Interviewees talked about the importance of communication in supporting a person-
centred approach, highlighting both the content of what is discussed but also the way in 
which communications are managed.  For example, it is important to find out from someone 
why they are not attending appointments: 
 
A lot of services would have discharged them because they’re not engaging 
because they’re not actively doing what they’ve told them to do...we don’t 
discharge on those grounds, we actually generally understand that when 
they’re not doing what you advise, people have a choice. (Group 1 - 
Frontline HSCP) 
 
It is also important to ensure that patients are fully informed about their care options as this 
can facilitate engagement, even where this may involve difficult but critical conversations.  
It was acknowledged again that time is needed as well as follow-up conversations.    
 
I think it is really important to be given all that information...we do need to 
convey the information and ensure that people understand it...I think the 
way it’s delivered sometimes by consultants in a 10/15 minute 
consultation, with no follow-up or quite often no options or support to 
actually look at how you could address this issue... although the doctors 
may think that they’ve conveyed that information, what that person hears 
is completely different. (Group 1 - Frontline HSCP) 
 
Poor communication can be very distressing both to those at the receiving end but also to 
their families.  The family KIs were told by hospital staff to provide personal care themselves 
to their loved one because staff were too busy.  That included this interaction:  
 
I changed the bed and I bagged everything up, I got these wipes and she 
said, ‘if you're going to make it, at least make it properly’ and I said ‘It’s not 
my fucking job’. (Family) 
 
The final component of a person-centred approach identified by interviewees was the need 
for the provision of personal care.  Good provision of personal care can facilitate 
engagement and compliance:  
 
I think it’s once they know that they’re not judged, they’re actually looked 
after, they’re given a nice wash, a nice bath, a nice dinner. (Group 1 - 
Frontline HSCP) 
 
This absence of personal care was most powerfully illustrated by the family who detailed 
the amount of personal care that they provided to their loved one, both while he was in 
hospital (where he died) and in the immediate aftermath of the death, alongside poor 
communication with hospital staff saying they did not have time to provide such care 
themselves.  Another interviewee said that there were limitations around the personal care 
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that hostel staff can provide for residents; for example, staff cannot clean up after someone 
who has wet themselves.   
 
Interviewees talked about two further considerations when delivering person-centred care.  
Namely, dealing with uncertain illness trajectories like those which usually surround liver 
disease as identified previously, and the need to proactively (rather than reactively) plan 
and manage care and risk.   
 
Moving on to planning care, and managing such uncertainty and risk, one interviewee said 
that the criteria for referrals to palliative or EoL care need to be “as broad as possible”.  
Another interviewee said there are clear markers of deterioration in patients with liver 
disease which mean that EoL care can be put in place.  Overall, interviewees talked about 
the need for care to be proactive rather than reactive and suggested ways in which this can 
be achieved.  For example, one interviewee said that, “you hope for the best but you plan for 
the worst”, while another said that, “we aim to be one step ahead of the game”.  
Interviewees suggested conducting risk assessments, and talking openly with patients, 
families and other professionals about potential or actual risks and how they can be 
mitigated.  Such considerations can be particularly important when organising community 
or home-based care, including medication requirements and communication with families:   
 
I think some of the examples I can think of where we’ve worked really well, 
is where from the start, we’ve said ‘this is going to be a problem patient’ 
from the point of view of it’s more complex, ‘what are we going to do to 
manage that?’...I think if you have all the health professionals who are 
willing to make it as good as it can be, then that’s a great way to do it and it 
is like having the risk assessments in, it’s talking to staff that feel a little bit 
anxious about things and from the outset, they’ve worked really well. 
(Group 1 - Frontline HSCP) 
 
We have built a good relationship with a lot of hospices...they really are 
quite proactive in trying to understand what the challenges are....to 
understand why that person may be presenting in such a challenging way 
and to try to look past that and look at the reasons for that. (Group 1 - 
Frontline HSCP) 
 
Overall, interviewees acknowledged that resources, time and fragmentation can affect the 
provision of such planning and proactive care.   
 
Joined up working 
Interviewees identified collaborative working as crucial to EoL care.  The role of 
commissioning in this regard was discussed earlier so the focus here is on practice.  One 
interviewee said that it was the absence of “wraparound support” for a client which 
triggered the need to do something to improve care for this group of people.  Interviewees 
discussed five issues in relation to joined up working; namely, treatment and palliation in 
parallel; tackling fragmentation; reciprocal expertise and knowledge; communication; and 
clarifying who is responsible for care.  Throughout this section the many challenges to 
joined-up working are also discussed.   
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Several interviewees highlighted the importance of professionals working together so that 
treatment and palliation could be delivered in parallel.  One interviewee thought that 
guidelines on advance care planning could include something to this effect, and that 
palliative care can be introduced even with patients who are on a transplant register.  Such 
parallel care is important for conditions like liver disease where, without such advance 
planning, palliative care often only happens in the last few hours or days before death.     
  
Fragmentation has already been identified as a barrier to compassionate and effective care 
and interviewees talked about tackling fragmentation, in some cases giving examples of 
collaborative working that had overcome potentially disjointed services, such as joint 
working and joint visits or multi-disciplinary case reviews or team approaches:   
 
Case reviews...for the most complex clients, they’re able to get some 
medical professionals to come to the hostel and talk about what’s 
happening and drug workers and various other people involved in their 
care...you're doing what you can with the homeless person and then 
working around and getting everybody involved because that seems to be 
a real problem with the fragmentation, that people don't really seem to 
know what’s going on and what each arm is doing and there needs to be a 
much greater sharing of information. (Group 4 – Other Professional) 
 
One interviewee implied that good joined up working practices can minimise the need for 
information sharing multiple times, and can ensure that care is oriented towards listening to 
what people want rather than what services think they need – both things which can also 
facilitate patient engagement.  Overall, interviewees recognised the benefits to joint 
working, and its importance when working with people who often have multiple morbidities 
and problems, although they emphasised that a lack of resources and the attitudes of some 
professionals can influence attempts to tackle fragmentation: 
   
If we can all work together....if just one of us of each can come together 
and keep talking, we’re going to do this, we’re going to make an 
improvement, it’s never going to be perfect but I believe we’ll have choices 
that will stop...some of the deaths happening in places where they 
shouldn't happen, it’s got to be collaborative, no doubt in my mind. (Group 
1 - Frontline HSCP)  
 
I do think that there is a real willingness of staff across all services to work 
in a multi-agency joined up way. We all understand that, we've all worked 
like that for years. But the difficulty is, that none of us have got the 
resources that we need to best meet the needs and to quickly meet the 
needs to save going round and round in circles. (Group 2 - Senior HSCP) 
 
Another important component of joined up working was the reciprocity of expertise and 
knowledge that can come from collaborative working.  As one interviewee said, “I think 
each of us has got to admit we’re not the expert”.  Interviewees gave examples of skill 
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sharing within multi-disciplinary teams, training packages, and accessing specialist guidance 
around prescribing for pain and symptom management: 
 
The patients will be referred to the Pathway team and they act as a focal 
point and a guidance point, both for the patient and for everybody else 
involved in their care...I think we’re very lucky that we can draw on the 
support and skills of many different professionals and people can get on 
board a lot quicker. (Group 1 - Frontline HSCP) 
 
Several interviewees highlighted the importance of good communication for effective 
collaborative working:   
 
I have to maintain good relationships with people, I can’t afford to get 
cross and nasty...I can’t afford to alienate people because I want them to 
work with me and I want them to see what they can’t see because their 
heads are running, they don’t have time to think of the niceties. (Group 1 - 
Frontline HSCP)   
 
Elements of this include understanding the role that each professional or service plays in 
care, being open and transparent, and managing anxieties that some professionals have 
about working with this group of patients.  Good communication can maximise proactive 
and compassionate person-centred care.  One interviewee thought that good 
communication, and hence collaborative working, was easier in local areas.  An interviewee 
also highlighted the value of communication in supporting community-based care: 
 
We try and draw on as many people in the community that are already 
known to the patient as well because sometimes you get a flavour because 
they’ve [e.g. pharmacists] always known the patient for a long time 
because they’ve been in and collected methadone, they get to know the 
patient well so they’ll pass on information. (Group 1 - Frontline HSCP) 
 
Finally, several interviewees thought that effective joined up working was affected by 
agreement about who was, or should be, ultimately responsible for that person and their 
care, including who should take the responsibility for initiating and managing conversations 
and planning around palliative and EoL care:   
 
What was often absolutely infuriating was when you've got somebody 
who's a drinker, who's got mental health problems, who's got one or two 
long-term conditions, who's got other needs...Which organisation is going 
to take responsibility? Which department is going to take the lead 
responsibility? Who's going to coordinate those services? Who's going to 
get them to the appointments? (Group 2 - Senior HSCP) 
 
... I think it delays the care that they need at that point because they’re too 
busy saying “Is it you or is it you?” (Group 1 - Frontline HSCP)  
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A few interviewees thought that some professionals or services were all too ready to push 
the responsibility on to someone else or another service meaning that, ultimately, people 
“fall between the gaps” and do not receive a joined-up response.  One interviewee cynically 
felt that some patients are left to fall through the net because it is easier to do that than 
establish who should be responsible for them.   
 
An interviewee gave an example of a GP who had a patient with cancer requiring palliative 
care but where the GP was told to pass the care for the person’s substance misuse over to a 
specialist service which the interviewee described as “bizarre”:   
 
Drug and alcohol users are often seen as somebody else’s problem, so if 
you're a GP, then their drug and alcohol use is somebody else’s problem. If 
you're actually the third sector providing the service, or the Mental Health 
Trust...then their physical comorbidities are somebody else’s problem. 
(Group 1 - Frontline HSCP) 
 
Then there’s the confusion or conflict even over who’s responsible for 
meeting the needs of somebody who’s terminally ill but is continuing to 
drink...we’ve had examples of Social Services saying, ‘We can’t help him 
until he stops drinking’, and you think ‘Is that likely to happen? Probably 
not so what you're essentially saying is that you can’t help at all because 
the drinking is not going to go away’. (Group 4 – Other Professional) 
 
Pain and symptom management 
This was one of the more prevalent themes in the data and had many elements to it.  These 
include the challenges of managing pain and symptoms alongside substance use including 
risk management; differing approaches to the problem between professionals; talking about 
pain and symptom management; education and training; issues related to families and 
peers; and working together.   
 
Interviewees highlighted many challenges and areas of clinical uncertainty when managing 
pain and symptom control alongside substance use.  This is an important area to get right 
to maximise the person’s engagement with the service and, medication compliance.  Issues 
raised include the following: 
 
• Levels of prescribing may need to be higher because of tolerance from historic drug 
use.  It may not be appropriate to prescribe at the low levels that might be detailed 
in clinical guidelines. 
• Professional reluctance to prescribe opioids particularly to those who are ex- or 
current users of opioid based drugs.   
• Abuse (including divergence) of drugs that are prescribed, and the risk of overdose.  
• Professionals need to understand that some people may resist or refuse some 
medications (for example, opioids) because of their history of substance use, and 
care needs to be adapted accordingly.   
• Managing medication on top of opioid substitution therapy (OST) and any other 
medications that a person may be receiving linked to their ill-health.  
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• Managing pain and symptoms with co-existing conditions like cancers including 
when diagnosis of EoL has come late. 
• Some patients will worry that their level of substance use will preclude them from 
having pain and symptom management at high enough levels.   
• Others may not be able to, or want to, stop using for a range of reasons, including 
unresolved underlying issues such as experiences of abuse or trauma.   
• In some cases, it can be advantageous to support someone to continue using (for 
example, because it can be dangerous to suddenly stop drinking alcohol or because 
the support is not in place to tackle the trauma behind the substance use). 
• Professionals may worry that a drug user has ulterior motives for also wanting 
medication for their pain and symptoms, including that they will abuse or divert the 
medication that they are prescribed.    
• Practical concerns such as keeping drugs safe in the home, and supporting patients 
who cannot swallow properly.   
 
Some interviewees gave examples of the sensitive management of ongoing use of 
substances alongside the management of pain and symptoms.  Ultimately, a comprehensive 
understanding of the patient along with skilled and compassionate clinical input is required: 
   
… I just reassure them that the team will take [their drug use] into account 
and ‘there won’t be a limit on your pain relief’ and I think that stops people 
stockpiling as well, if you give guarantees that your pain relief will be the 
main focus, if you need higher amounts of drugs, you’ll get them. (Group 1 
- Frontline HSCP)  
  
The doctor said he needed to be sorted out and it was important that he 
stayed on these medications and he didn’t come off them. But the doctor 
also said, ‘This cold turkey idea thing, I don't think it’s fantastic...Ideally he 
needs to still drink but nowhere near as much, even if it’s only one glass a 
day’. (Family)   
 
There were a small number of examples where the attitudes and perceptions of 
professionals affected the approach to pain management with this group of people: 
     
We talk about the pain...what the patient tells you it is but that doesn't 
seem to apply to this group in terms of other people, ‘so they’re looking for 
drugs, they’ve asked for it four hourly’, whereas if it was a wee old lady 
who was 80 who was asking for extra painkiller, they’d be paging us going, 
‘She’s really sore, you need to come and do something about it’. (Group 2 - 
Senior HSCP) 
 
I guess where we hear about things that are of concern clinically will be 
things like people being afraid to prescribe analgesia properly, particularly 
if somebody has a heroin or some kind of a drug related abuse...my clinical 
experience is that some people, particularly with heroin abuse or related 
drugs, have a very high tolerance for the drug and therefore they need 
really big doses...people are really afraid of really big doses and so I think 
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that there is a tendency to underserve this population. (Group 3 - Policy & 
Commissioning Professionals) 
 
Examples of steps that had been taken to manage such identified risks included arranging 
with a chemist for the daily delivery of drugs to a home, safe storage boxes for medications 
in the home, and a pub landlady who looked after the medication for one isolated pub 
regular: 
 
His next of kin was the [pub] landlady...she kept the ‘just in case’ 
medications9 for use and they were the ones that kept out for his safety 
because they were aware when he didn’t come in, so there are inbuilt 
support mechanisms from that. (Group 1 - Frontline HSCP) 
 
A challenge to the management of pain and symptoms can be the differing views and 
approach of professionals.  One interviewee said that professionals do not worry that a 
cancer patient will become a morphine addict and that there should be no difference when 
talking to substance use patients about the right titration of medication for them.  One area 
where opinion was likely to differ was whether a person should be asked or told to stop 
their own substance use to receive medication for pain and symptoms, particularly opioid 
medication.  This can cause difficulties with substance use treatment services who often 
advocate for abstinence. One interviewee described a three-way reluctance re opioid 
medications at times: 
 
I think there is a reluctance for doctors to prescribe opioids, there’s a 
reluctance for patients who might be off opioids to want to take it if you 
think that’s appropriate...I think there’s reluctance from nursing staff to 
give opioids. (Group 2 - Senior HSCP) 
 
A small number of interviewees mentioned specific drugs and the challenges posed when 
medicating for pain and symptoms.  This included managing someone who stopped 
cannabis use because of the way it blocked their pain, suggesting the need for a more 
creative use of Librium in the community, and the use of Naloxone10:  
 
It would not be appropriate to give someone who has palliative care and 
cancer pain, a huge dose of Naloxone and reverse all the opioids and so for 
me, there was some education [needed for] the team that I was working 
with in terms of how we use it, they hadn’t heard of it and used in a 
different way. (Group 2 - Senior HSCP)  
 
As has been identified elsewhere, interviewees highlighted the importance of talking about 
the dual issues of pain/symptom management and substance use, and of the need to be 
well informed to have such conversations: 
                                                     
9 ‘Just in case’ medications are prescribed by a GP or nurse for use in the event of people experiencing pain at 
night or during the weekend. They can be given in tablet or injectable form. 
10 Medication which can block the effects of opioids such as heroin and which is commonly used when 
someone overdoses. Take home naloxone programmes are widespread across the UK, targeting both drug 
users and carers in the emergency administration of Naloxone.  
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We do tell them that we’re not being judgemental...[but]...we are going to 
need to take this into account when we are looking at things to control 
your pain. (Group 1 - Frontline HSCP) 
 
I wouldn't be averse to having a conversation...saying, ‘this is what we’re 
giving you, what else are you taking in the day that we don't know about, 
be honest with me because we need to try it’ and titrate doses accordingly. 
I need to have some kind of a baseline to make those decisions on and 
actually if you’ve got that kind of relationship, that’s normally okay isn't it? 
(Group 1 - Frontline HSCP) 
 
Interviewees talked about the need for professionals to be adequately educated and trained 
in the issues surrounding pain and symptom control and how to discuss it with this group of 
patients.  One interviewee said that the complexity of liver disease pharmacology means 
that prescribing requires expertise and careful management.   
 
I suppose [liver specialists] we could provide better guidance for hospices 
in terms of pharmacological management of patients with liver disease at 
the end of life, because I think hospices are very nervous of liver disease. 
(Group 2 - Senior HSCP) 
 
Another interviewee said that a patient with dual addiction and cancer issues triggered a 
realisation that they did not know how to manage their care and that there were no local 
guidelines in place to help with this.  Someone else commented on the vagueness of British 
Pain Society guidelines and their focus on analgesia.  Another interviewee said that drug 
treatment clinical guidelines were being updated to include more on pain management. 
They also mentioned a resource from the Faculty of Pain Medicine called Opioids Aware to 
help guide good practice around prescribing of opioid medications. Overall, there was 
recognition that this is an area where more specific guidance would be valuable. 
 
Several interviewees recognised the need for greater awareness of the involvement of 
families and peers around the patient and whether they can positively support, or actively 
disrupt, care plans around pain and symptom control.  For example, the presence of other 
drug users in a household is an important consideration when needing to prescribe (and 
potentially also store) drugs in the patient’s home, but can also bring temptation for ex- or 
active users or the risk of people stealing or diverting medicines: 
 
Thinking about families and the whole dynamics around someone dying 
and opioids may be coming into the house and what that throws up for the 
family, if they’ve gone through a drug misuse episode and someone’s 
recovered and then opioids are coming back...there may be other people in 
the family who are at risk of misusing the medicines that are coming in. 
(Group 3 - Policy & Commissioning Professionals) 
 
A lot of old friends that they’ve known from over the years find out that 
they’re unwell, these people... start to come into the household when 
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actually they’ve not seen that person for a while. (Group 1 - Frontline 
HSCP) 
 
Concern about the family, particularly where there are identified risks, can be stressful for 
the person who is dying:   
 
The person who is dying usually is quite stressed about it, if they are aware 
of the substance misuse of their relative, it causes an awful lot more 
trauma for them, they’re a lot more unsettled, quite often find there’s lots 
of fights amongst the family and police involvement and things when 
somebody is actually dying, which then you're trying to support everybody. 
(Group 1 - Frontline HSCP) 
 
Interviewees talked about working with other professionals to handle this issue, giving both 
examples of good practice in this area but also examples of difficult situations.  Examples of 
good practice included working with pharmacies around dispensing of medications where 
there might be risks for taking such medications in to the home; liaison with other 
professionals led to one patient moving from legal highs for pain to receiving a pain patch; 
joint working between hospital and addictions team to agree the most appropriate 
prescribing; working with GPs who might be the focal contact for prescription management; 
and Consultant expertise where required:  
 
We will get our consultants to see these patients at home or in clinic here, 
just so that we can actually get them to say this is the appropriate dose for 
this patient because if a nurse was saying this is the appropriate dose, that 
wouldn't be deemed right...when we know we’re going to have somebody 
who we are going to need to use bigger doses, we will get the consultant to 
see them and we’re lucky because we have the ability to actually take them 
to their homes. (Group 1 - Frontline HSCP) 
 
My experiences of doctor and nurse prescribers are really good and really 
creative and not formulaic...when people say ‘I’d rather drink than take 
morphine’, he’ll say ‘you can take both’, rather than ‘yeah you're right’. So 
they work with the patient and that’s what I’ve experienced. (Group 1 - 
Frontline HSCP) 
 
Interviewees also gave examples of difficulties in this area. This included one interviewee 
who talked about GPs who were reluctant to agree to drugs going in a patient’s home 
because of their substance use history, and another who said that patients were being sent 
back to hostel from hospital without the medication that they needed.  The service user 
described a confusing incident when he said he would consider moving on to a different 
drug, and then found out when he next went to collect his methadone that his prescription 
had been stopped and he would be starting the new drug but would have to go a day or so 
without his methadone.  This made him cross and frustrated.   
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Care settings 
Interviewees talked about many key services that this group of patients come in to contact 
with and the successes and challenges in working with each.  This included GPs and primary 
care, drug and alcohol treatment, hospitals, hostels (and other forms of accommodation for 
homeless people), hospices, mental health services, social care, criminal justice system, and 
pharmacists.  There were also one-off references to other professional groups.   
 
GPs and Primary Care 
Broadly, interviewees recognised the potential for, and importance of, GPs being at the 
heart of a developing response, but equally recognised the challenges with this.  One 
interviewee said that the loss of shared care and local GP contracts had negatively impacted 
upon primary care work with substance users and work with treatment services.  Most 
people have good access to their GP and, even though some people with substance use 
problems engage poorly with services like primary care, when they do present they can 
often place high demands on GPs which means that opportunities for improving care 
(including palliative and EoL care) are there:.  
 
I haven't yet met someone who has gone to their GP once with significant 
symptoms and been referred in, they tend to have presented over months 
and months. (Group 2 - Senior HSCP) 
 
However, identification within primary care is hard or does not happen and the knock-on 
effect of this is that people with problematic substance use (and potential EoL issues) are 
not identified (or are not identified in a timely way).  This means that some people will not 
be placed on the primary care palliative care register with one interviewee saying that 
registers should be extended to capture end stage liver failure or COPD in drug users, in the 
same way that they extended from cancer to include COPD and heart failure.  The reasons 
behind these identification and referral challenges include: the stigmatisation of this group 
of patients by GPs who do not feel that there is much that they can do for them, GPs who 
push for abstinence from substances which can alienate patients, practical issues for those 
patients who move around a lot or who do not have or do not engage with their GP.  Two 
interviewees highlighted the way forward for primary care and the key role that it can play 
because of access to both the patient group and a wide range of local services:  
 
So unless we get the pathways commissioned it really is going to be about 
trying to convince GPs to incorporate this client group into their current 
palliative care arrangements....[there is a] key coordination role for general 
practice. (Group 1 - Frontline HSCP)  
 
The family key informants generally had a good experience of GPs who were trying to help 
their relative, including stepping in when they could see that care from other professionals 
(mainly hospitals) was not adequate.  
 
Drug and Alcohol Treatment 
As seen earlier, interviewees talked about the impact of the disintegration of drug and 
alcohol services.  For example, one hospital professional talked about having more distant 
relationships with services and their staff (including hospital-based alcohol nurses) which 
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makes it harder to co-work patients.  Another interviewee said there was very little access 
to substance use treatment services in their area while another suggested that treatment 
services are segregated from other services.  There was also a sense that substance misuse 
treatment services are less well informed about EoL issues and are not adequately set-up to 
be able to respond to the needs of this group.  Similarly, there was a sense that treatment 
services are inflexible, largely through their focus on recovery, the pressure to meet targets 
(including payment by results), and the rigid structures around prescribing.  However, a 
small number of interviewees cited examples where good joint working around prescribing 
is possible, and both the service user and family KIs talked positively about the help they 
had received from drug and alcohol treatment services.  
 
Hospitals 
Interviewees talked mostly about three main aspects of hospital care for people with co-
existing substance use and EoL care needs; namely, liver consultants and teams (this was 
most talked about), A&E departments, and palliative care teams.  Generally, as has been 
seen elsewhere, people with substance use problems can be a difficult patient group to 
identify and then work with because of the unpredictable trajectory of their conditions 
(usually discussed in relation to liver disease).  They place pressure on hospitals because of 
their (often frequent) hospital attendance and admissions, particularly to A&E.  Some 
interviewees suggested that this group of patients do not always listen to hospital advice 
and so can be viewed negatively by hospital professionals: 
 
[It] can be challenging for hospital staff, if you've got someone that’s 
coming in and discharging and going and having a can and coming back, it 
can be quite disruptive and if you're very stretched time wise, services are 
extremely stretched, if you have someone that’s particularly challenging to 
work with, it’s not always met with the same compassion that you would 
hope for. (Group 4 – Other Professional) 
 
Some interviewees felt that hospitals are not always adequately set up for the delivery of 
palliative care.  However, some interviewees were also clear that, for some patients, 
hospital is the ‘right’ place for them die.  There were mixed experiences of links with 
hospital-based palliative care teams, with the following positive example of collaboration 
between the two sections of hospital care:    
 
The complications of liver disease can be dramatic towards the end of 
life...it’s often quite ghastly and we can make it better and we work very 
hard with our palliative care physicians within our hospital. We’re very 
lucky to have very strong links and very good palliative care physicians to 
do that. (Group 2 - Senior HSCP) 
 
A couple of interviewees said that it can be really difficult to introduce conversations about 
palliative care and EoL with patients, particularly younger patients.  However, it was also 
recognised that hospital professionals have a key role to play in initiating conversations and 
that, overall, hospitals can do better when responding to liver disease:   
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If we want to make a start about actually improving the death, hospital is 
the place to start. (Group 2 - Senior HSCP)  
 
One interviewee (not a hospital professional) talked about the importance of having good 
links with hospitals in order to work with clients using substances but said that 
fragmentation between hospitals and substance use treatment services can affect such 
work.   
 
As will be seen later, while the family KIs mentioned one or two hospital professionals who 
provided good care to their relative, they (and their relative) were much more likely to have 
had negative and distressing experiences of hospitals - before, at, and after, the death of 
their loved one.  The service user KI also talked about his poor experiences of hospital staff 
when they told him about the severity of his condition.  He also felt the way he was told that 
he had been turned down for a heart transplant was not handled well.   
 
Hostels and accommodation for homeless people 
It was widely recognised by a number of interviewees that health and social care services 
face particular challenges in caring for homeless people.  Their needs can be complex, often 
accompanied by chaotic and isolated lifestyles. The negative ways in which they are often 
perceived can greatly affect the identification of their needs and their engagement with 
appropriate services even though the potential for timely intervention is there because of 
their frequent engagement with some services, for example, hospitals:    
 
Even just the label of homelessness, it can be quite difficult to access some 
services. (Group 1 - Frontline HSCP) 
 
Interviewees identified a number of challenges around working with this group of people.  
These included availability and choice around dry or wet hostels, finding accommodation 
(including for those who are still using substances), liaison with treatment services who 
often focus on recovery, low staff: resident ratios, and difficulties in delivering the clinical 
care and personal care usually required because of the limitations of hostel care:  
 
I think really the big challenges that we’ve found have been for people that 
are drinking or using substances, who are extremely ill...the very physical 
nature of a hostel is not set up to cater for the kind of needs that 
somebody with serious prolonged substance misuse might have. (Group 4 
– Other Professional) 
 
One interviewee described how they had adapted a training pack for hostel staff working 
with EoL care in homeless populations to also cover substance use.  Overall, this seemed to 
be a sector where there was greatest recognition of the needs of people with substance use 
and EoL care needs, and of steps being taken to tackle the multiple issues which arises for 
them.  Interviewees highlighted the importance of a collaborative, multi-disciplinary, 
proactive and creative approach to intervention with the client at the centre of care. 
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Hospices 
Generally, KIs recognised that hospices remain very cancer dominated and are not set-up to 
meet the complex needs of people with substance use and EoL care issues.  Some key 
informants believed that people also assume that hospice care is not the right for them or 
that they will not be accepted:   
 
Hospices are not necessarily set up for patients with addiction issue and 
are not necessarily set up for the social chaos that often comes with 
families with alcohol [problems]... . (Group 2 - Senior HSCP) 
 
However, a small number of interviewees suggested that there is something of a sea change 
happening.  They stated that hospices are an under-utilised resource with a positive impact 
on patient behaviour and quality of life, and can support people with ongoing substance 
use:    
 
They do a remarkable job of managing people with complex symptoms... 
they are considered the masters of symptom management and generally 
they do manage, even with behaviour problems and it’s amazing how their 
behaviour becomes more compliant in a setting like this. (Group 1 - 
Frontline HSCP) 
 
The service user KI, who attends a day hospice, talked in mostly positive terms about his 
experience of hospice care but was clear that he does not want to disclose his drug use 
(particularly to fellow residents) because of how he thinks he will be viewed:  
 
It has no need to rear its ugly head... so there’s no stigma stuck to me. 
(Service user) 
 
He also commented about feeling ‘out of place’ because of his younger age, suggesting that 
there could be (for example) support groups tailored to younger people in hospices. 
 
Other 
A small number of interviewees talked about other services that have contact with this 
group of people, such as social care, the criminal justice system, and pharmacists.  There 
was almost no mention of mental health services, which is perhaps concerning given the 
high association between mental health and substance use, and the potential role such 
services could have in supporting this group of people with EoL care needs.  Similarly, few 
interviewees talked in any detail about social care.  Those who did mention social care 
described it as a system under great pressure and therefore unable to do much for this 
group. This lack of social care involvement was perceived to be because of high thresholds 
for social care intervention resulting in late identification of needs and delayed care.  
Multiple carers were identified by one interviewee as affecting care because such 
inconsistency meant that carers did not fully know the patient and understand their needs.  
Two interviewees talked about prisons although one very briefly.  It was also seen as a 
system under pressure, and a system which, culturally, does not sufficiently recognise the 
needs of this group of people and is not in a position to do very much by way of response.   
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Four interviewees talked briefly about pharmacists, and usually did so in positive terms.  It 
seemed that this was an area of care with untapped potential.  Pharmacists had a particular 
role to play in offering both community-based support and in supporting the safe provision 
of medication, including in cases where it is unsafe for medicines to be going in to the home: 
 
We have some pharmacies that are very good, some pharmacies that are 
‘no, we won’t deliver to the hostel, sorry, they have to come down and pick 
it up’...when you do have great relationship with pharmacies who are really 
flexible and understanding and work well together, that usually comes 
down to having a compassionate or lovely pharmacist who managed a 
service, or somebody who is championing the cause of homeless people or 
people with substance use issues, rather than it being a blanket service 
level understanding of the need for flexibility with this client group. (Group 
1 - Frontline HSCP) 
 
There was almost no mention of some key professions in the EoL sector such as MacMillan 
nurses.  One interviewee mentioned district nurses, saying that they are stretched 
profession and an under-utilised resource.  The family KIs talked about a poor experience 
when a district nurse visited their relative but was unable to meet the person’s needs and 
essentially “turned round and walked out the house”.  On the other hand, the family 
recounted positive support from the coroner.  One interviewee said that there is a lack of 
good psychological support for this group of patients:  
 
We’ve got a lot of people who’ve got those substance misuse problems 
and already have a past that chases them on top of major regrets...they will 
sometimes offload that onto you so you carry that burden for them and 
quite often, it can be things that they don’t want others to know...I'm not 
trained to deal with that level of psychological problems, so you do end up 
using an awful lot of time trying to deal with that side… (Group 1 - Frontline 
HSCP) 
 
In summary, interviewees talked about some of the key issues which influenced the delivery 
of care, particularly a person-centred approach, joined-up working, and pain and symptom 
management.  The key components of a person-centred approach identified by 
interviewees were relationships, holistic care, accessible and flexible care, communication, 
and the provision of personal care.  In relation to joined up working, interviewees 
highlighted the importance of treatment and palliation in parallel; tackling fragmentation; 
reciprocal expertise and knowledge; communication; and clarifying who is responsible for 
care.  Pain and symptom management was one of the more prevalent themes in the data 
and interviewees discussed the challenges of managing pain and symptoms alongside 
substance use; differing approaches to the problem between professionals; talking about 
pain and symptom management; education and training; issues related to families and 
peers; and working together.  Interviewees also talked about their experiences of care in key 
settings including primary care, drug and alcohol treatment, hospitals, hostels and hospices. 
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 3.3.iii  (Not) talking about substance use or death and dying 
The third theme in the ‘Engaging and Responding’ thematic cluster centred around the topic 
of talking about substance use or death and dying.  Interviewees described three areas 
where conversations could be difficult to have with people with EoL and substance use 
issues: substance use itself; giving and receiving an EoL diagnosis; and death and dying 
including palliative and EoL care.  
 
Substance use 
Interviewees discussed if, when, and how to, talk about substance use to those with EoL 
issues.  Some KIs stated they had difficulties asking people about their substance use, 
particularly for those working in palliative or EoL care.  The main issue debated by 
interviewees was whether people should be asked, or told, to stop drinking or taking drugs 
at the end of their lives, or whether their wish to continue using substances should be heard 
and accounted for when planning EoL care.  Two interviewees explained that they and their 
service were happy to work with people regardless of their substance use:  
 
The fact that we recognise that there will always be some people who can’t 
stop drinking and we will always offer them a hand of support and that is 
different and yes, I think it therefore makes it philosophically easier for us 
to work with continuing drinkers, even though we know that they are at 
the end of their life whereas some people would not do that, they could 
take a harsher view I guess. (Group 2 - Senior HSCP) 
 
I certainly am very flexible, if you want to change, that’s fine, if you phone 
someone up and you're really drunk, fine, I’ll see you tomorrow, so there’s 
no pressure, if I said ‘if you want to cancel and go and get drunk, go and get 
drunk’. (Group 1 - Frontline HSCP) 
 
However, for other interviewees, continued substance use can be a barrier to engagement.  
One interviewee said that they were aware of cases where social services had refused to 
work with people until they stopped using while another commented that some patients 
are told to stop smoking which they implied was pointless under the circumstances. 
 
So now they've got to cope with withdrawing from nicotine as well...you 
see them really struggling and you think it’s not going to [make] a blind bit 
of difference and if you get relief from it, just go for it...we’re quite relaxed 
towards it. (Group 1 - Frontline HSCP) 
 
The family said that their relative could not cope with going ‘cold turkey’ (from alcohol) 
particularly as he received no medication to help the withdrawal symptoms.  Subsequently, 
a doctor said that this was not a good idea and that he should continue to drink but try to 
keep to very small amounts.  Interviewees also discussed the pros and cons of giving or 
receiving ‘wake-up calls’; in other words, clear messages that if they continued using then 
they would die.  Some interviewees, including the service user KI, could see the benefits to 
such an approach: 
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[My addiction’s] just been a crutch that I’ve not fully been able to kick until 
this has happened...I suppose it does take something drastic before you 
really do wake up and smell the coffee and that is what’s happened. 
(Service user)  
 
Sometimes that wakeup call that they got from the doctor will scare the 
bejesus out of them and they’ll be going, ‘Right, I need to change my life, 
turn it around, get me into detox’, they attend all of the alcohol groups, 
they really engage with services, they go to detox, they go to rehab. (Group 
1 - Frontline HSCP) 
 
However, other interviewees identified drawbacks with such a ‘shock tactics’ approach, 
including the loss of hope which such a message might give and experience of knowing 
patients who have received a wake-up call yet survived which can make such messages 
meaningless, “like water off a duck’s back”:  
 
It’s a wakeup call...and sometimes that can work but quite often, people 
would turn the other way and have their hope removed entirely, so if they 
have no hope then what else is there to do but continue to drink or do the 
things that bring them some relief? (Group 1 - Frontline HSCP) 
 
Every time they come in, a different doctor tells them, “If you don’t stop 
drinking, you're going to die” and then they don’t die and they keep 
drinking, they come into hospital again and they believe it slightly less the 
next time. (Group 2 - Senior HSCP)  
 
Several interviewees said that their preferred approach was to attempt to discuss substance 
use openly with people (in the context of their illness[es] and any prescribing requirements), 
and then listen and try to cater for their wishes, rather than to demand abstinence.  Within 
such conversations it can be possible to discuss the disadvantages of continued substance 
use, while emphasising that care or medication will not be withdrawn or limited if substance 
use continues, rather it will be adapted accordingly.  For some KIs it seemed that how 
messages are communicated, and how client choice is supported, were more important 
than the messages themselves.  Delivery, content and follow-up are all important:   
 
Let them know that ‘we do not want to take you away from this situation 
at this moment in time, we don’t want you to stop drinking, we don’t want 
you to stop living your life how you have always lived it’, what we want to 
do is support you. (Group 1 - Frontline HSCP) 
 
if you planned assuming people would continue to drink instead of 
believing that they won’t because they’ve told you, I think you could 
improve care. (Group 2 - Senior HSCP) 
 
Some interviewees, within the context of debates around recovery, questioned the 
legitimacy of expecting abstinence for someone clearly at the end of life.  Another 
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interviewee made a similar point by describing how they tackled such conversations with 
patients by shifting the focus away from substance use and choice.  
 
I’ve found an interesting approach that worked for me....’Okay, we’ve seen 
you twice this last six months, you’ve had several alcoholic hepatitis, you've 
had a variceal bleed, your kidney function’s deteriorating, obviously 
stopping drinking is not something that’s possible for you’. And then you 
take that off the table straightaway, you don’t ask them to stop drinking, 
you sort of take alcohol away and say ‘...so now because this addiction is 
part of your illness, we need to start thinking about how we’re going to 
plan the end of your life’....you take away the, ‘If you don’t stop drinking, 
you’ll die’....and change the focus to ‘Drinking is part of your pathology, we 
need to deal with that in the same way as we need to deal with your liver 
chemistry’.  (Group 2 - Senior HSCP) 
 
Following on from this some interviewees gave examples of ‘good deaths’ for people who 
had been supported to continue taking substances right up until death. One interviewee 
talked about a patient who was prescribed anti-nausea medication before and after drinking 
so that she could continue to drink.  Other examples were: 
  
Someone who died last week, sitting up in bed sipping whisky, someone a 
couple of weeks ago said, ‘what are you eating and drinking?’, she said ‘red 
wine and smoked salmon’, perfect!  And I think that’s as important as end 
of life drugs. (Group 1 - Frontline HSCP) 
 
There’s one guy who’s just died in the hospice, he was having two bottles 
of wine a day and he was just like a big sign up, do not disturb before 11 o 
clock’ … and that’s where he wanted to die and what’s what he wanted to 
do. (Group 1 - Frontline HSCP) 
 
The hospice have allowed them to continue to drink, although they can’t 
officially say that, the drinks trolley will come round twice a day for them 
rather than just once and so there is that flexibility and person-centred 
approach. (Group 1 - Frontline HSCP)  
 
Finally, the service user KI felt that a possible solution would be to warn people to not get 
involved with substances in the first place, using the real-life examples of people like him: 
   
[I’d] warn them against getting involved with drugs because it’s an absolute 
mug’s game, it’s virtually killed me and it’s a game of roulette...So I’d just 
advise people to think twice. Don’t be like me and let it run your life for 20 
odd years... something that you take which is meant to make you feel good 
and have a good time, ends up nearly killing me, pretty much ruining my 
life, and then walks away laughing at me for being a mug. (Service user) 
 
Giving and receiving an EoL diagnosis 
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Somewhat surprisingly this area did not feature greatly in the data. One interviewee, a liver 
consultant, said that such conversations often did not happen because the focus of some 
professional groups was on saving lives and getting people well (including through 
transplant) adding that there can be a particular reluctance to diagnose EoL in young 
people:    
 
Your instinct is not necessarily to palliate, it’s to save, often to a ridiculous 
degree. (Group 2 - Senior HSCP) 
 
Another interviewee asked who was best placed to have such conversations, particularly 
with vulnerable and complex populations like homeless people.  The service user KI, who 
had been attending a heart clinic for about six months, talked about the ‘bolt out of the 
blue’ when he was told that he would die and was asked about hospice admission. He had 
also been refused a heart transplant:  
 
‘How do you feel about going there?’.... I was scratching my head thinking, 
why do I need to go to a hospice?...Then almost in the same breath, the 
nurse explained, she said ‘you know you're very ill?....you're really ill...you 
could have as little as a year to three years to live’....it felt like a kick in the 
stomach. (Service user) 
   
Death and dying including palliative and EoL care 
Building on findings presented above around how to manage client choice around substance 
use at the end of life, a number of interviewees talked about the importance of a proactive 
and collaborative approach with patients, which focused on what they want for their end of 
life:    
 
So rather than talking about treatment preferences, it’s more about your 
preferences generally, like what do you want for the rest of your life?  
What do you want it to look like?  What can we change? (Group 4 – Other) 
 
It’s a person-centred approach that palliative care/end of life care needs to 
take, it’s so where are they now and...how can we improve where you are 
or your end of life experience, how can we make that what you want it to 
be? (Group 1 - Frontline HSCP) 
 
One interviewee talked about improving care in the hospital setting in order to facilitate 
conversations about dying because that is where the majority of people with problematic 
substance use will die.  The family described an example of appalling hospital care for their 
loved one and for themselves, including an absence of conversations about their loved one’s 
death.  For example, at one point when the family suggested that their loved one needed to 
be in a hospice, hospital staff said that “there’s nothing we can do about that”:   
 
However, importantly the service user KI emphasised that there should also be awareness 
about when someone might not want to talk about their death:  
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It’s in the forefront of my mind, no matter how many times I push it to the 
back and it might not be healthy to [keep] pushing it all at the back  but at 
this particular stage, it’s how I feel comfortable coping with it and I feel 
that I'm reminded of it regularly enough, that I don’t need to be moping 
about it or mulling over it in my own head, it’s dragged to the surface and 
as I say, almost on a weekly basis, in one form or another. (Service user) 
 
In summary, interviewees described three areas where conversations could be difficult to 
have with people with EoL and substance use issues: substance use itself; giving and 
receiving an EoL diagnosis; and death and dying, including palliative and EoL care.  
Interviewees discussed the importance of choice around substance use, rather than 
demanding abstinence, that ‘wake up calls’ often do not work, and the importance of a 
proactive and person-centred approach to discussing end of life with someone.   
 
3.3.iv  Families and networks 
The fourth theme that emerged in this thematic cluster has a focus on families and social 
networks.  Not all interviewees talked about families and networks, and those who did, did 
not do so at great length.  The exception is the three family members who were interviewed 
together about their son/nephew and his end of life care, and who offered an insight into 
the potential experiences of families.  Topics covered under this theme include the 
experiences of families, the perceptions of families and professionals towards each other, 
issues regarding death certificates and the official cause of death, and support for families 
both before and after death.   
 
Experiences of families 
Only a few professionals made any comment that indicated that they were aware of the 
ways in which families can be affected by having a loved one with a substance use problem, 
and how they can continue to be affected at the end of life:   
 
The family that are around will have had a lot of, or a bad time with them 
over the years and quite often, through guilt, will continue to look after 
them but will have been treated quite badly. (Group 1 - Frontline HSCP) 
 
I just think families is going to be one of those, a big issue for our client 
group as they approach the end of life. (Group 3 - Policy & Commissioning 
Professionals) 
 
In terms of how families can be affected, professionals mentioned anger, guilt, strain, 
conflict, estrangement, and blaming their loved one.  One professional made a specific 
comment that encephalopathy11 “is deeply unpleasant for families to deal with....gastro 
intestinal bleeding at home is not nice”.  Several interviewees commented that clients are 
often isolated and estranged from their family.  Some family members may themselves be 
ex- or current users, which can bring complexity and chaos to already difficult situations.   
 
                                                     
11 A general term to describe brain disease or damage.  
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Inevitably, the family KI talked at great length about their relative’s addiction and 
subsequent ill-health which led to his death.  They described the impact of multiple 
interactions with health professionals (mainly GPs and hospital staff) over a lengthy period 
of time and while they described some good and compassionate care what dominated the 
interview was an upsetting chronology of poor care of their relative, covering the time 
before death, the death itself and the period afterwards.  For example, they described how 
quickly their relative’s health deteriorated when multiple symptoms emerged seemingly 
overnight and he became very ill.  There were then numerous distressing incidents while 
their loved one was in and out of hospital and during his final admission when he died.  This 
included a drain being put in back to front (which led to blood poisoning; the person was 
still waiting for a transfusion when he died), the mother describing how much personal care 
she delivered to her son after being told that hospital staff were too busy (washing and 
changing him, shaving him, cutting his toe nails, changing the bedding), and a DNR (do not 
resuscitate order) not being put in place so that attempts were made to resuscitate him 
which caused great discomfort.  Moreover, poor communication from the hospital meant 
that the family was not able to be with their relative when he died, and they had to cope 
with knowing that he died alone and in great distress, and that he was not in a private room:  
 
He was definitely in pain when he died...he was definitely struggling… 
(Family) 
 
Poor care continued after death as the body was not looked after (the mother’s personal 
care of her son continued) and it was several hours before it was taken away.  Additionally, 
there was misinformation about the post mortem, and the family had to get chaplain 
themselves despite several requests, which the hospital said they never received.  Together, 
what this family says illustrates the great stress and strain which the family was placed 
under.  While they highlight that some professionals showed more compassion towards 
them and their relative (GPs, one nurse and the coroner), they experienced more poor care 
and, ultimately, hold the hospital responsible for ‘killing’ their relative and want them to be 
held to account.  However, the family’s complaints were all disputed by the hospital, which 
only added to their grief.  The family knew that their son was dying but know (largely from 
the coroner) that he did not need to die at that time and in such a distressing way.  
Ultimately, the family felt that he was not afforded the same care and rights as someone 
without substance use problems.  
 
Perceptions of families and professionals towards each other 
Interviewees gave examples of how families could either positively or negatively impact 
upon the dying person.  Overall, interviewees were more likely to talk about how they, or 
others, perceived families and networks negatively, giving examples of how families and 
networks can have a negative impact on the dying person and on the care that is given to 
those who are dying.  Examples included causing disruption in hospital, being physically and 
verbally aggressive towards hospital staff, disagreement within families and with hospital 
staff about their loved one’s care, airing views that the person had brought their problems 
on themselves, and wanting the focus to be on them, and how they are suffering rather 
than maintaining focus on the person who is dying, and blaming professionals for their loved 
one’s condition and death.  Interviewees also expressed concerns about the presence of 
drug-using family members or peers which can impact upon care, particularly in the home, 
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for example, concerns about other people’s use of the person’s prescribed medication.  A 
more positive perspective came from the family KIs who described all the love and care that 
they tried to offer to their relative particularly in the absence of the poor care that person 
was receiving in hospital.   
 
In terms of how families view professionals, insights again came only from the family KIs.  
They gave examples of both good and poor care, thereby presenting mixed views about the 
numerous professionals they, and their relative, had contact with.  The family described 
good care from GPs, some nursing staff, and staff/volunteers at an alcohol service:   
 
There was only one nurse on that ward in the whole time [he] was there, 
that was decent, that did her job...she was absolutely lovely...she was the 
one that made sure that [he] got everything he needed and nothing was 
too big for her, no job was too big or small, she would help if she could and 
everything you asked, she made an effort for. (Family) 
 
I think that the work they’ve [alcohol service and volunteers] done has 
been absolutely fantastic with this family. (Family) 
 
However, on the flip side the family were extremely distressed by the poor care and attitude 
of the majority of staff at the hospital where their loved one died and referred to a letter 
they received from the hospital in response to their complaint: 
 
I can’t understand where all these apologies are coming from because 
she’s put, ‘[Matron] would like to apologise for any undue distress caused 
to yourselves and your grandson on arrival at [the ward], it was not our 
intention to cause upset’, well if it wasn’t your intention to cause upset 
then why did you neglect it in so many different ways and when we 
actually came to speak to you, did you not be empathetic? Why did they 
always have a stern, cold exterior to everything that they said? Whenever 
you spoke to them, it was so abrupt and there was no feeling, there was 
nothing there...I know sympathy and empathy are two very different things 
but they should at least empathise with the family. (Family) 
 
Issues regarding death certificates and the official cause of death 
A small number of interviewees talked about families who feel very strongly that they do 
not want alcohol or drugs to be named on a death certificate and hence the official cause of 
death of their loved one:   
 
Families do not like alcoholic liver disease, so they do not want that putting 
on the death certificate, so there’s pressure on doctors who’ve got a family 
that’s recently bereaved...Quite often, they don’t mind the fact that he was 
an alcoholic during life but they don't want it putting on his death 
certificate. (Group 4 – Other Professional) 
 
One interviewee described in more detail how this situation might play out, and the impact 
this can have on official statistics:  
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The junior doctors always get phoned up by the bereavement office the 
next day, to say they’ve seen a death certificate, the family really don’t like 
it, please can you take the word alcohol off? That’s a very common 
phenomenon, the number of alcohol- related deaths are probably under-
reported because of that...you’ve got a grieving family that often aren’t 
brilliantly emotionally equipped to deal with that in a sort of calm way, and 
you can see something that will immediately reduce their grief, and there 
are ways around it, you can write ‘decompensated hepatic cirrhosis’, none 
of that’s a lie, you can dress it up and that sometimes makes people 
happier. (Group 2 - Senior HSCP) 
 
One interviewee said that it can be difficult for families if a death has to be referred for a 
post mortem or to a coroner because that family “think they’ve done something wrong or 
someone’s over prescribed, the police have to come and it’s horrendous”.  The family KIs 
described helpful communication with the coroner about their loved one’s death, which 
helped clarify key things like the time of death and that such a distressing death could, and 
should, have been avoided.   
 
Support for families before and after death 
Interviewees talked about the need for families to be supported both before and after the 
death of their relative.  One interviewee talked about the need for more pre-bereavement 
counselling for families and children while another also highlighted an absence of 
psychological support to families who have been treated badly by their loved one yet who 
may feel guilt for what has happened:   
 
There is a massive need for them to get psychological support, to actually 
deal with it...there’s limited availability in the area, we don’t have Level 4 
psychological support, so it’s us who supports them to look after and it can 
be very difficult because there’s two needy people there who are needing 
access to support. (Group 1 - Frontline HSCP) 
 
Interviewees also talked about supporting a person who is at the EoL to connect with family 
before they died.  For example, as a result of EoL training, staff at one hospital were 
proactive in helping a man find and reconnect with his estranged family before he died:  
 
By the time this gentleman died, he had contact with his family which he 
hadn’t had for many years. (Group 1 - Frontline HSCP) 
 
The family KIs experienced positive support from a number of sources, including the vicar, 
their local community, a spiritualist and, particularly, one non-statutory alcohol service who 
continued to support them after the death:   
 
[The alcohol service] are the only people that have been an absolute rock 
to this family since [relative’s] passing, [volunteer] I couldn't thank him 
enough, I will be eternally grateful to [volunteer] for what he’s done...from 
the word go when they first come here, they put themselves out that much 
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to do things for [relative and us], they took us both in like family and 
helped us right the way through... they’ve provided after-care to the family 
that have been bereaved and they need to be recognised for that. (Family) 
 
Through this alcohol service the family was also able to attend a bereavement support 
group and talked about what they found helpful about this:  
 
We talk to [another lady]...she had the same thing, she had the same loss, 
more or less identical to [us] and we had a talk with her and a cry, you 
know, but she feels exactly the same, let down by the hospital the same as 
we feel...neglect, sheer neglect, nothing else. (Family)   
 
In summary, interviewees talked about the experiences of families, the perceptions of 
families and professionals towards each other, issues regarding death certificates and the 
official cause of death, and support for families both before and after death.  Overall, 
families were more likely to be viewed negatively, and there was limited recognition and 
discussion of the needs of families both before and after the death of their loved one.     
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Section 4 - Discussion and implications 
The headline findings from the qualitative analysis of the KI interviews are summarised 
below (see Box 2):  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Overall, the interviews identified similar issues at both national and local levels, and across 
substance use and palliative and EoL care.  At times it makes for bleak reading, with 
interviewees talking about professions and systems under enormous multiple pressures and 
which, along with stigma and prejudice, mean that this group of patients (and often also 
their families) is unlikely to receive the right care at the right time and delivered in the right 
way.   
 
However, the interviews also contain optimism and hope for how the needs of this group of 
people should be best met.  Characteristics of good care, and pockets of good practice, were 
highlighted, all of which could be harnessed to raise awareness, encourage more good 
practice and tackle stigma.   
 
In talking about the characteristics of this group of people, the diversity that interviewees 
discussed means that a ‘one size fits all’ response will be insufficient.  Rather, the 
developing care response must cater for a group of people that has a very wide ranging 
demographic profile who are most likely to present with multiple, and often chronic and 
longstanding, physical, psychological and social problems.  Interviewees were more likely to 
discuss groups such as homeless people and those in lower socio-economic groups, 
suggesting that while concepts such as the alcohol harm paradox (e.g. Bellis et al., 2016) 
must be accounted for, care must be taken to not overlook, for example, the sizeable 
number of people in the middle and higher socio-economic groups who have alcohol 
problems.  Furthermore, it seems that this is a group of people who receive unequal care 
and it is unfortunate that they are not listed as such in EoL inequalities agendas (e.g. CQC, 
Box 2: Headline Findings from the KI Interview Analysis 
1. Current definitions and ways of understanding palliative care, and addiction 
recovery, do not easily apply to people with substance use and EoL concerns.  
2. The patient/client group is not a straightforward one – there are often complex 
and multiple physical, psychological and social morbidities which impact upon 
identification, engagement with services and the delivery of care.  
3. There are significant issues with the fragmentation and inflexibility of services 
which affect care – however, it is possible to identify the characteristics of a good 
joined-up and compassionate approach to care.   
4. Substance use receives little attention in national or local policy around palliative 
and EoL care; and palliative and EoL care receives little attention in national or 
local policy around substance use.    
5. Prescribing for pain and/or symptom management for people with substance use 
and EoL concerns is a complex area; but good practice which facilitates someone 
to continue drinking or using drugs if they wish is possible. 
6. Families can be viewed negatively, and receive little support, either alongside 
their loved one and/or in their own right and both at the EoL and after death.   
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2016). For the most part within EoL care there is a continued focus on cancer, and within 
substance use services on recovery.  The analysis of this dataset suggests that these two 
dominant paradigms are impeding the development of the most appropriate response to 
people with co-occurring substance misuse and EoL issues.   
 
Pain and symptom management was one of the most dominant themes across the 
interviews. This aligns with a key finding of the Rapid Evidence Assessment undertaken as 
part of the wider research project on EoL care for people with substance problems within 
which these interviews took place (Witham, Peacock, & Galvani, 2018).  It is, inevitably, an 
important area of care and clinical concern, but one which rarely accounts for client choice 
and either ongoing substance use or the wishes of ex-users (who, for example, may not wish 
to be prescribed certain drugs). However, some of the interviews gave examples of good 
practice where patients were supported to continue drinking alcohol or taking drugs, and 
how this had a positive impact on their care experience.   
 
Across the interviews there was limited discussion of the needs of families and a sense that 
families/networks are viewed quite negatively by professionals (although not necessarily by 
the KIs themselves).  This aligns with other research which has highlighted the experiences 
and needs of families affected by a loved one’s substance use or who are bereaved by 
substance use, and of the disconnect between these needs and the amount of help and 
support that is available (e.g. Adfam, 2018; Valentine, 2018).  The experiences and needs of 
families have been the focus of another strand of this project and are reported in detail 
elsewhere (Wright et al., 2017; Yarwood et al., 2018).   
 
Overall, interviewees were critical of policy and commissioning, and also identified a 
number of challenges and barriers which are impeding the provision of timely, holistic and 
adequate care.  These reflect wider dilemmas and challenges which are facing both 
substance misuse treatment and palliative and EoL care (e.g. ACMD, 2017; Adfam, 2017; 
Marie Curie, 2015).  Given the multiple and complex needs of many people with substance 
use and EoL concerns, there is a greater need for multi-disciplinary and joined up care and 
care pathways and for national and local policy and commissioning practice to reflect this.  
There is also a need for resources and guidance to help professionals, in a range of settings, 
identify and engage with the dual issues and a programme of workforce development that 
can support people to feel comfortable and confident to talk about these issues with 
patients, families and colleagues. 
   
4.1  Implications for Research, Policy and Practice 
The analysis suggests a number of implications for research, practice and policy – these are 
listed below.  
 
Implications for Research 
1. How can current definitions and ways of understanding palliative care, and addiction 
recovery, be better applied to people with substance use and EoL concerns? 
2. What might the core components be of an improved national and local policy response 
to this group of people? 
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3. How can we better understand the complexities of prescribing for pain and/or symptom 
management, including for those who wish to continue drinking or using drugs?  What 
are the components and facilitators of good practice and in this area? 
4. Given the diversity of the KI sample, there is potentially a need for similar research to 
further explore the key issues which have arisen and how they might apply to different 
professional groups across England/the UK.  
5. How does care need to differ to meet the needs of sub-groups of people with substance 
use and EoL concerns – for example, by gender, age, ethnicity, nature of substance use?  
 
Implications for Practice and Policy 
1. There is a need for greater reciprocity in national and local policy, where palliative and 
EoL policy considers the needs of those with substance use concerns, and substance use 
policy considers the needs of those with palliative and EoL care needs.  
2. Practice and policy, at both national and local levels, needs to be fully holistic in order to 
better meet the needs of families alongside their loved one and/or in their own right.  
3. There is a need for guidance, and improved inter-service collaboration, to support the 
earlier identification of, and engagement with, a complex group of people who are often 
reluctant to engage with services.  
4. There is a need for guidance on issues surrounding prescribing, and how they can be 
addressed while not compromising the care of those who wish to continue drinking or 
taking drugs.  
5. Practice guidance is needed to support services to meet the needs of sub-groups of 
people with problematic substance use and end of life conditions. 
  
4.3  Strengths and limitations to the research 
There are both strengths and limitations to this KI dataset.  A key strength to the dataset is 
that it has, for the first time, brought together the experiences of a diverse cohort of 
individuals from a range of settings and disciplines working, or living with, the overlapping 
issues of problematic substance use and EoL care.  In terms of limitations, the diversity of 
the interviewee cohort was also a limitation and made analysis challenging.  There is 
possibly some interviewee selection bias as interviewees were generally known or 
suggested to us.  It is, therefore, not possible to generalise from these findings alone.  
However, given that many of the findings align with findings from other strands of the wider 
project, and with other similar research, some generalisation may be possible.   
 
 
Conclusion 
The KI interviews have given a unique, and hitherto unknown, insight into the experiences 
and challenges of working with adults with substance use problems and EoL concerns.  
Interviewees highlighted numerous individual, organisational, and strategic level challenges 
to identifying this group of people and delivering timely, efficient, joined up and 
compassionate care.  There is much to do to better meet the needs of a sizeable, but largely 
neglected group of adults and their families. These interviews offer constructive suggestions 
for how care can be improved.   
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Appendix 1 – Analysis Template v2 
 
THEMATIC CLUSTER 1: THE WIDER LANDSCAPE 
 
1. Size and Nature of the Problem 
1.1 National Data 
1.1.1 Drug-related deaths (incl. within Tx, out of Tx, overdoses) 
1.1.2 Alcohol-related deaths 
1.1.3 Accuracy of & challenges with measuring & reporting 
1.2 Client profile and demographics 
1.2.1 Gender 
1.2.2 Age  
1.2.2.1 Young 
1.2.2.2 Old 
1.2.3 Substances 
1.2.3.1 NPS 
1.2.4 Other conditions 
1.2.4.1 Cancers 
1.2.4.2 Smoking and COPD 
1.2.4.3 Hepatitis C 
1.2.5 Complex presentations and multiple morbidities 
1.2.5.1 General comments and reflections 
1.2.5.2 Traumatic pasts 
1.2.5.3 Mental health (incl. learning disabilities and cognitive 
impairment) 
1.2.5.4 Homeless 
1.2.5.5 Social  deprivation and disadvantage 
1.3 Tip of the Iceberg incl. ignored, invisible & increasing awareness 
1.3.1 Becoming aware (‘one case made me think’) 
1.4 Local examples of prevalence and worker caseloads 
1.5 Thoughts on future prevalence  
 
2. Commissioning and Delivery 
2.1 National commissioning picture 
2.1.1 Drugs and Alcohol 
2.1.2 Palliative and End of Life Care  
2.2 The response/the system is.... 
2.2.1 Fragmented 
2.2.2 Inflexible 
2.2.3 Stretched (covering staff & money) 
2.3 National and local practice and commissioning agendas 
2.3.1 Too mainstream – cancer dominated 
2.3.2 Need for dedicated roles, services and champions 
2.3.3 Lack of local direction and guidance 
2.3.4 Geographical variation and postcode lotteries 
2.3.5 Need for integrated and/or specialist commissioning 
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2.3.6 Centralised or community/home approaches 
2.3.7 Comparisons with how things used to be 
2.3.8 General thoughts on policies, pathways & guidance 
2.4 Financial considerations 
2.4.1 Lack of money 
2.4.2 How to attract funding incl. ‘hooks’ & research 
evidence 
 
3. Definitions and Perceptions incl. one comment re substance use & addiction 
3.1 Palliative and End of Life Care  
3.1.1 Applicability to substance use/misuse 
3.2 Recovery & applicability to SM & EOL 
3.3 Death and dying (and conversations about) 
3.3.1 Notions of a ‘good’ death  
3.3.2 The right place to die 
3.3.2.1 The 4 H’s (hospitals, hospices, hostels & 
home) 
3.4 Professional perceptions of the client group 
3.4.1 Characteristics  
3.4.1.1 Difficult & unpopular, a nuisance and 
non-compliant 
3.4.1.2 Underserved, different & viewed 
differently to other groups 
3.4.1.3 Fall through the net 
3.4.1.4 Not taken seriously 
3.4.1.5 Don’t see the whole person 
3.4.2 Impact on professional approach  
3.5 Perceptions from wider society 
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THEMATIC CLUSTER 2: ENGAGING AND RESPONDING 
 
3. Families and Networks  
6.1 Experiences of families 
6.2 Negative impact on the dying person 
6.3 Positives in having around the dying person 
6.4 Lack of family/support 
6.5 Connecting with family before death 
6.6 Negative attitudes towards families and peers 
6.7 Issues regarding prescribing for pain management 
6.8 Attitudes of families towards professionals 
6.9 Issues wrt cause of death and death certificate 
6.10 Support for families 
6.11 Bereavement 
 
7 Engaging Clients 
7.1 Screening and assessment  
7.2  Identification 
7.2.1 Uncertain illness trajectories incl. masking 
7.2.2 Too late 
7.2.3 Crisis, chaos and complexity incl. frequent 
attenders/missed 
7.3 Referrals 
7.4 Client barriers 
7.4.1 Resistant to engage 
7.4.2 Experiences incl. mistrust/suspicion of 
profs/services 
7.4.3 How perceived by professionals 
7.4.4 Access to services 
7.4.5 Self stigma, being unworthy 
 
8 (Not) talking about...... 
8.1 Substance use 
8.1.1 Continuing or stopping 
8.1.2 Different professional viewpoints 
8.1.3 Client choice 
8.1.4 Zero tolerance 
8.2 Giving and receiving an ‘eol’ diagnosis 
8.3 Death and dying and end of life incl. planning/care 
8.4 Walk up calls – you’ll die 
8.4.1 Bouncing back and cheating death 
 
9 Managing and developing care responses 
9.1 Uncertain illness trajectories 
9.2 Planning & managing including risk, anticipatory not reactionary 
9.3 Joined up working 
9.3.1 Treatment and palliation in parallel  
76 
 
9.3.2 Tackling fragmentation 
9.3.3 Reciprocity of expertise and knowledge 
9.3.4 Communication 
9.3.5 Challenges 
9.3.6 Whose responsibility is it? 
9.4 Examples of good practice and of joint working 
9.4.1 National 
9.4.2 Local 
9.5 Person-centred approach 
9.5.1 Relationships – trust and honesty 
9.5.2 Holistic 
9.5.3 Accessible & flexible 
9.5.4 Communication 
9.5.5 Providing personal care 
9.6 Pain and symptom management  
9.6.1 Alongside use 
9.6.2 Different approaches and views 
9.6.3 Clinical uncertainty and challenges incl. risk 
management 
9.6.4 Client attitudes and concerns 
9.6.5 Talking about  
9.6.6 Education and training 
9.6.7 Families and peers (using and non-using) 
9.6.8 Working together and the role of other profs 
9.7 Components of care  
9.7.1 GPs (and primary care) 
9.7.2 Drug and alcohol treatment 
9.7.3 Hospitals 
9.7.4 Hostels etc. (i.e. other accommodation for the 
homeless) 
9.7.5 Hospices Mental health services 
9.7.6 Social care – incl. housing (or separate??) 
9.7.7 CJS incl. police & prison 
9.7.8 Pharmacists 
9.7.9 Other 
9.7.10 Workforce development including limitations & 
need for training 
 
 
